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Commentary
The HIV/AIDS surveillance data in this report
characterize the populations affected by HIV-related
illness and death and provide a current profile of HIV/AIDS
at the national level. The epidemic’s impact on the nation’s
health was highlighted during 1995, when the cumulative
number of reported AIDS cases surpassed one-half
million. Of 513,486 persons with AIDS reported through
December 1995, over 62 percent have died. Among
persons ages 25 to 44 years, HIV infection is now the
leading cause of death in men and the third leading cause
in women. As expected, the number of cases reported
during 1995 (74,180) was lower than the numbers
reported during 1994 (79,897, Table 1) and 1993
(105,828), reflecting the waning effect of the expanded
1993 AIDS surveillance case definition. However, in 1995
the number of cases reported was 56 percent higher than
in 1992 (47,453), before the case definition was
expanded.
Because the numbers of cases reported annually
during the period 1992 through 1995 have fluctuated, and
because persons reported with AIDS during a calendar
year had AIDS diagnosed during that year or prior years,
CDC has developed statistical methods to examine
temporal trends in the epidemic (see Technical Notes).
These methods estimate the incidence of AIDS
opportunistic illnesses (AIDS-OIs) by taking into account
the change in the case definition and lags in reporting of
cases to CDC. Results show that from 1992 through 1994,
the estimated incidence of AIDS-OIs increased by 8
percent overall. Trends in the incidence of AIDS-OIs
varied by region, race/ethnicity, sex, and mode of
exposure (Tables 18, 19, 20). From 1992 through 1994,
the incidence of AIDS-OIs increased in the South (13
percent) and the Northeast (11 percent), and among
blacks (17 percent), Hispanics (13 percent), men (5
percent), and women (26 percent). Increases also
occurred among Asians/Pacific Islanders and American
Indians/Alaska Natives; however, these populations each
account for less than 1 percent of estimated AIDS-OIs. By
mode of HIV exposure, the largest increases occurred
among heterosexual men and women who acquired HIV
through injecting drug use (men 11 percent; women 12
percent) or through heterosexual contact (men 38
percent; women 46 percent). Although the incidence of
estimated AIDS-OIs is increasing most rapidly among
persons infected heterosexually, men who have sex with
men continue to represent the largest number and
proportion of persons estimated to have AIDS-OIs.
The demographic characteristics, behavioral risks, and
geographic distribution of persons with AIDS reported
during 1995 reflect shifts in the populations at risk for HIV/
AIDS, most notably the changing racial/ethnic profile
shown on the cover of this report. The cover illustrates a
shift in the epidemic from whites to minorities, especially
blacks and Hispanics. In 1995, for the first time, the
proportion of persons reported with AIDS who are black
was equal to the proportion who are white (40 percent). In
1995, blacks and Hispanics represented the majority of
cases among men (54 percent) and women (76 percent).
The reported AIDS incidence rate per 100,000 among
blacks (92.6) was 6 times higher than that among whites
(15.4) and 2 times higher than that among Hispanics
(46.2). Rates were lowest among American Indians/
Alaska Natives (12.3) and Asians/Pacific Islanders (6.2).
However, HIV/AIDS surveillance data collected from
medical records do not include measures of socioeco-
nomic status such as education and income that may
more accurately predict risk of HIV than demographic
factors such as race/ethnicity.
Case report information obtained by health care
providers through routine patient history-taking may
include one or more risk behaviors or potential modes of
exposure to HIV (Table 17). Efforts to prevent HIV
infections through community-based prevention pro-
grams are enhanced by knowledge of HIV risk behaviors
in the local community. Most adults/adolescents reported
with AIDS have risk information recorded (93 percent,
Table 3). Although persons most recently reported with
AIDS are more likely to have unreported risk information
because medical record reviews are incomplete or
pending, most persons are ultimately identified as having
a recognized risk factor (Figure 7). HIV reports provide a
minimum estimate of the number and characteristics of
persons in the community who have been tested for HIV;
however, a higher proportion of HIV than AIDS reports
has incomplete HIV exposure information. Persons
reported with HIV (not AIDS) are younger, more likely to
be women and black or Hispanic minorities, and more
recently infected than persons reported with AIDS
(Tables 22 through 26). HIV surveillance data should be
interpreted with knowledge of local practices because
they are influenced by the availability of HIV test facilities
and the proportion of HIV-infected persons who seek or
defer HIV testing.
Among men reported with AIDS in 1995, male-to-male
sexual contact again accounted for the largest proportion
of cases (51 percent), followed by injecting drug use (24
percent, Table 4). These proportions will increase slightly
as exposure information is completed for persons initially
reported without a risk for HIV infection (13 percent).
Among young men (ages 20 to 24 years), male-to-male
sexual contact and/or injecting drug use accounted for 76
percent of AIDS cases and 63 percent of HIV infection
cases reported in 1995 (Tables 7 and 25, respectively).
Women accounted for 19 percent of adult/adolescent
AIDS cases in 1995, the highest proportion yet reported
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among women. Most women acquired HIV infection
through injecting drug use (38 percent) or sexual contact
with a man with or at risk for HIV infection (38 percent,
Table 5). The injecting drug use-associated epidemic
among men is reflected in the heterosexual epidemic
among women.  Women may not recognize or report the
risk behaviors of their partners, and health care providers
may only record the HIV/AIDS status of a woman’s male
partners and not her partners’ risk behaviors. Therefore,
an increasing proportion of women are likely to be
classified in the exposure category “sex with HIV-infected
person, risk not specified.”
The epidemic in women is reflected in the epidemic in
children, nearly all of whom acquired HIV infection
perinatally. In 1995, 84 percent of children reported with
AIDS were black or Hispanic, and AIDS rates per 100,000
population among black and Hispanic children were 16
and 6 times higher (6.4 and 2.3, respectively) than among
white children (0.4, Table 10). The number of children
reported with AIDS in 1995 (800) was lower than that
reported in 1994 (1,034). Changes in surveillance
practices, the number of infected women giving birth, and
the clinical management of women and children may each
have contributed to this decline. Studies are underway to
determine the relative contributions of each of these
factors. In 1995, the 28 states that reported HIV infection
(not AIDS) among children reported 229 pediatric AIDS
cases and 342 pediatric HIV cases (Table 24). In these
states, reports of children perinatally exposed to HIV (with
subsequent follow-up to determine infection status) will be
useful in evaluating the impact of Public Health Service
guidelines on preventing perinatal transmission (see
Suggested Reading).
The 1993 expansion of the AIDS surveillance case
definition has caused fluctuations in the numbers of
reported AIDS cases during the past 3 years. However,
reporting trends are gradually stabilizing. Each year since
1993, a larger proportion of persons with AIDS was
reported based on immunologic criteria added to the case
definition. State-to-state fluctuations in reporting patterns
may reflect a number of factors, including use of
laboratory-initiated reporting of severe immunosuppres-
sion, enhanced surveillance efforts in some states, and
increases in AIDS incidence in some geographic areas. In
many of the states (Table 1) and metropolitan areas
(Table 2) that reported more cases in 1995 than in 1994,
HIV was introduced later than in the bicoastal epicenters,
where the epidemic emerged early in the 1980s. However,
reported AIDS incidence rates per 100,000 population
remained highest in Puerto Rico, New York, Florida, New
Jersey, Maryland, and Connecticut, and in heavily
affected metropolitan areas, many of which are in these
same states (e.g., Jersey City, San Francisco, West Palm
Beach, San Juan, Baltimore, New Haven, Orlando, and
Hartford).
To promote the uses of national HIV/AIDS surveillance
data for tracking the epidemic, for program planning and
evaluation, and for facilitating comparisons to state and
local surveillance data, the HIV/AIDS Surveillance Report
is now available through the Internet. See page 2 of this
report for the address of CDC’s home page.
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Table 1. AIDS cases and annual rates per 100,000 population, by state, reported in 1994 and 1995; 1
and cumulative totals, by state and age group, through December 1995, United States
1994 1995 Cumulative totals
Adults/ Children
State of residence No. Rate No. Rate adolescents <13 years old Total
Alabama 582 13.8 642 15.1 3,611 52 3,663
Alaska 59 9.8 69 11.4 324 4 328
Arizona 610 15.0 678 16.1 4,436 19 4,455
Arkansas 285 11.6 277 11.2 1,863 27 1,890
California 12,132 38.6 11,134 35.2 88,447 486 88,933
Colorado 812 22.2 673 18.0 5,212 26 5,238
Connecticut 913 27.9 1,652 50.4 7,257 153 7,410
Delaware 269 38.0 316 44.1 1,484 12 1,496
District of Columbia 1,400 246.9 1,029 185.7 8,041 116 8,157
Florida 8,522 61.1 8,059 56.9 50,726 1,112 51,838
Georgia 2,266 32.1 2,291 31.8 14,393 156 14,549
Hawaii 216 18.3 259 21.8 1,784 13 1,797
Idaho 61 5.4 49 4.2 326 2 328
Illinois 3,062 26.0 2,220 18.8 16,221 190 16,411
Indiana 617 10.7 529 9.1 3,802 30 3,832
Iowa 130 4.6 116 4.1 867 8 875
Kansas 233 9.1 320 12.5 1,614 10 1,624
Kentucky 318 8.3 298 7.7 1,812 14 1,826
Louisiana 1,230 28.5 1,087 25.0 7,568 98 7,666
Maine 117 9.4 130 10.5 702 6 708
Maryland 2,686 53.7 2,575 51.1 12,826 240 13,066
Massachusetts 1,382 22.9 1,447 23.8 10,493 171 10,664
Michigan 1,021 10.8 1,201 12.6 7,345 81 7,426
Minnesota 419 9.2 369 8.0 2,690 19 2,709
Mississippi 429 16.1 442 16.4 2,377 37 2,414
Missouri 707 13.4 791 14.9 6,360 45 6,405
Montana 30 3.5 25 2.9 192 2 194
Nebraska 88 5.4 114 7.0 682 7 689
Nevada 384 26.3 493 32.2 2,627 21 2,648
New Hampshire 92 8.1 112 9.8 616 7 623
New Jersey 4,872 61.7 4,409 55.5 28,704 623 29,327
New Mexico 213 12.9 164 9.7 1,232 4 1,236
New York 14,729 81.1 12,399 68.4 92,972 1,779 94,751
North Carolina 1,188 16.8 1,000 13.9 6,329 91 6,420
North Dakota 21 3.3 5 0.8 65 – 65
Ohio 1,193 10.7 1,110 10.0 7,540 90 7,630
Oklahoma 268 8.2 295 9.0 2,442 17 2,459
Oregon 605 19.6 459 14.6 3,386 14 3,400
Pennsylvania 2,510 20.8 2,377 19.7 14,891 198 15,089
Rhode Island 275 27.7 223 22.5 1,411 14 1,425
South Carolina 1,151 31.6 976 26.6 5,337 63 5,400
South Dakota 20 2.8 19 2.6 101 4 105
Tennessee 751 14.5 897 17.1 4,670 42 4,712
Texas 5,847 31.8 4,477 23.9 34,830 284 35,114
Utah 153 8.0 164 8.4 1,169 20 1,189
Vermont 38 6.5 44 7.5 272 3 275
Virginia 1,155 17.6 1,610 24.3 7,782 134 7,916
Washington 929 17.4 892 16.4 6,783 24 6,807
West Virginia 92 5.0 127 6.9 617 8 625
Wisconsin 373 7.3 350 6.8 2,498 23 2,521
Wyoming 19 4.0 17 3.5 133 – 133
Subtotal 77,474 29.8 71,411 27.2 489,862 6,599 496,461
Guam 1 0.7 – – 14 – 14
Pacific Islands, U.S. – – – – 2 – 2
Puerto Rico 2,283 62.5 2,594 70.3 15,978 335 16,313
Virgin Islands, U.S. 52 50.1 39 37.4 249 12 261
Total 2 79,897 30.2 74,180 27.8 506,538 6,948 513,486
1See Technical Notes for a discussion of the impact of the 1993 AIDS surveillance case definition for adults and adolescents (implemented January 1, 1993)
on the number of cases reported annually since 1993.
2Totals include 435 persons whose state of residence is unknown.
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Table 2. AIDS cases and annual rates per 100,000 population, by metropolitan area with 500,000 or
more population, reported in 1994 and 1995; 1 and cumulative totals, by area and age
group, through December 1995, United States
1994 1995 Cumulative totals
Adults/ Children
Metropolitan area of residence No. Rate No. Rate adolescents <13 years old T otal
Akron, Ohio 46 6.8 37 5.5 319 – 319
Albany-Schenectady, N.Y. 144 16.5 204 23.4 1,040 20 1,060
Albuquerque, N.Mex. 90 13.9 92 13.9 680 2 682
Allentown, Pa. 76 12.4 88 14.3 489 6 495
Ann Arbor, Mich. 24 4.7 54 10.3 272 5 277
Atlanta, Ga. 1,550 46.5 1,556 45.3 10,355 84 10,439
Austin, Tex. 456 47.2 323 32.3 2,635 17 2,652
Bakersfield, Calif. 104 17.0 126 20.4 615 3 618
Baltimore, Md. 1,868 76.0 1,715 69.4 8,448 173 8,621
Baton Rouge, La. 178 31.9 121 21.5 851 13 864
Bergen-Passaic, N.J. 638 49.0 559 42.7 3,767 64 3,831
Birmingham, Ala. 167 19.1 194 22.0 1,121 14 1,135
Boston, Mass. 1,179 20.6 1,266 21.9 9,337 149 9,486
Buffalo, N.Y. 100 8.4 84 7.1 877 10 887
Charleston, S.C. 165 32.0 146 28.8 981 10 991
Charlotte, N.C. 185 14.7 244 18.9 1,302 14 1,316
Chicago, Ill. 2,732 35.6 1,912 24.8 14,165 170 14,335
Cincinnati, Ohio 243 15.4 195 12.2 1,288 12 1,300
Cleveland, Ohio 306 13.8 429 19.3 2,203 32 2,235
Columbus, Ohio 277 19.5 192 13.4 1,607 10 1,617
Dallas, Tex. 1,359 46.8 1,289 43.6 8,691 34 8,725
Dayton, Ohio 88 9.2 48 5.0 646 8 654
Denver, Colo. 615 34.3 522 28.5 4,225 18 4,243
Detroit, Mich. 684 15.9 794 18.4 5,083 60 5,143
El Paso, Tex. 89 13.3 139 20.5 549 2 551
Fort Lauderdale, Fla. 1,443 104.2 1,271 90.0 8,019 182 8,201
Fort Worth, Tex. 544 37.1 213 14.3 2,171 22 2,193
Fresno, Calif. 106 12.7 144 17.1 792 8 800
Gary, Ind. 94 15.2 77 12.4 429 3 432
Grand Rapids, Mich. 83 8.4 98 9.8 527 3 530
Greensboro, N.C. 207 18.7 200 17.8 1,084 16 1,100
Greenville, S.C. 187 21.4 126 14.2 883 2 885
Harrisburg, Pa. 97 15.9 128 20.9 549 5 554
Hartford, Conn. 394 35.3 561 50.3 2,476 40 2,516
Honolulu, Hawaii 149 17.0 180 20.5 1,313 10 1,323
Houston, Tex. 1,889 51.7 1,158 31.2 12,459 114 12,573
Indianapolis, Ind. 308 21.1 232 15.7 1,852 11 1,863
Jacksonville, Fla. 268 27.7 454 46.4 2,901 62 2,963
Jersey City, N.J. 820 148.7 760 138.1 4,680 101 4,781
Kansas City, Mo. 300 18.2 359 21.6 2,918 12 2,930
Knoxville, Tenn. 112 17.8 69 10.8 434 5 439
Las Vegas, Nev. 326 30.2 385 33.8 2,060 20 2,080
Little Rock, Ark. 96 17.8 86 15.8 686 10 696
Los Angeles, Calif. 4,375 47.9 3,997 43.7 30,885 200 31,085
Louisville, Ky. 136 13.9 144 14.6 807 8 815
Memphis, Tenn. 273 25.9 323 30.2 1,671 14 1,685
Miami, Fla. 3,070 151.8 2,381 117.2 15,975 397 16,372
Middlesex, N.J. 409 38.2 350 32.4 2,247 61 2,308
Milwaukee, Wis. 209 14.4 195 13.4 1,350 14 1,364
Minneapolis-Saint Paul, Minn. 371 13.8 318 11.7 2,371 16 2,387
Mobile, Ala. 110 21.5 118 22.8 736 9 745
Monmouth-Ocean City, N.J. 346 33.4 340 32.4 2,028 50 2,078
Nashville, Tenn. 214 20.0 277 25.3 1,446 14 1,460
Nassau-Suffolk, N.Y. 565 21.3 585 22.0 4,439 76 4,515
New Haven, Conn. 448 27.6 948 58.3 4,199 106 4,305
New Orleans, La. 698 53.3 594 45.2 4,404 51 4,455
New York, N.Y. 12,958 151.1 10,496 122.5 79,984 1,620 81,604
Newark, N.J. 1,844 95.4 1,681 86.8 11,521 270 11,791
Norfolk, Va. 352 23.0 603 39.1 2,019 51 2,070
Oakland, Calif. 969 44.4 655 29.8 5,918 33 5,951
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Table 2. AIDS cases and annual rates per 100,000 population, by metropolitan area with 500,000 or
more population, reported in 1994 and 1995; 1 and cumulative totals, by area and age
group, through December 1995, United States (Continued)
1994 1995 Cumulative totals
Adults/ Children
Metropolitan area of residence No. Rate No. Rate adolescents <13 years old T otal
Oklahoma City, Okla. 117 11.6 118 11.6 1,123 2 1,125
Omaha, Nebr. 53 8.0 78 11.6 480 2 482
Orange County, Calif. 505 19.9 570 22.2 4,063 25 4,088
Orlando, Fla. 576 42.2 709 51.0 3,636 62 3,698
Philadelphia, Pa. 1,923 38.9 1,810 36.6 11,489 163 11,652
Phoenix, Ariz. 431 17.4 504 19.7 3,205 11 3,216
Pittsburgh, Pa. 297 12.4 234 9.8 1,718 10 1,728
Portland, Oreg. 483 28.8 341 19.9 2,822 8 2,830
Providence, R.I. 259 28.4 206 22.7 1,320 13 1,333
Raleigh-Durham, N.C. 268 27.7 170 17.1 1,285 20 1,305
Richmond, Va. 223 24.3 287 30.9 1,584 19 1,603
Riverside-San Bernardino, Calif. 875 30.1 768 26.0 4,617 42 4,659
Rochester, N.Y. 216 19.8 297 27.3 1,304 8 1,312
Sacramento, Calif. 315 21.9 383 26.3 2,276 21 2,297
Saint Louis, Mo. 367 14.5 423 16.6 3,169 27 3,196
Salt Lake City, Utah 130 11.0 136 11.3 1,023 14 1,037
San Antonio, Tex. 543 37.9 419 28.7 2,644 23 2,667
San Diego, Calif. 963 36.6 1,068 40.4 7,299 45 7,344
San Francisco, Calif. 2,585 157.4 2,135 129.7 22,800 35 22,835
San Jose, Calif. 391 25.2 262 16.7 2,278 11 2,289
San Juan, P.R. 1,446 75.7 1,502 77.9 9,969 213 10,182
Sarasota, Fla. 193 37.3 155 29.5 938 19 957
Scranton, Pa. 37 5.8 47 7.4 284 3 287
Seattle, Wash. 601 27.6 645 29.4 4,942 14 4,956
Springfield, Mass. 222 37.3 186 31.4 1,037 21 1,058
Stockton, Calif. 114 22.0 74 14.1 508 12 520
Syracuse, N.Y. 91 12.1 106 14.1 732 7 739
Tacoma, Wash. 83 13.0 73 11.2 540 7 547
Tampa-Saint Petersburg, Fla. 751 34.8 709 32.5 5,474 74 5,548
Toledo, Ohio 59 9.6 37 6.0 373 8 381
Tucson, Ariz. 137 18.7 120 15.9 913 6 919
Tulsa, Okla. 78 10.5 91 12.2 744 6 750
Ventura, Calif. 66 9.4 70 9.9 532 2 534
Washington, D.C. 2,368 53.0 2,130 47.2 14,435 205 14,640
West Palm Beach, Fla. 708 74.2 810 83.3 4,566 159 4,725
Wichita, Kans. 68 13.4 99 19.5 454 2 456
Wilmington, Del. 226 41.8 265 48.5 1,167 9 1,176
Youngstown, Ohio 33 5.5 40 6.6 232 – 232
Metropolitan areas with
500,000 or more population: 66,934 41.1 60,912 37.1 427,754 5,874 433,628
Central counties 65,695 44.1 59,552 39.7 420,032 5,766 425,798
Outlying counties 1,239 8.8 1,360 9.5 7,722 108 7,830
Metropolitan areas with
50,000 to 500,000 population: 7,816 16.3 8,045 16.6 49,440 662 50,102
Central counties 7,300 17.1 7,589 17.6 46,467 605 47,072
Outlying counties 516 9.8 456 8.6 2,973 57 3,030
Non-metropolitan areas 4,648 8.7 4,737 8.8 27,109 395 27,504
Total 2 79,897 30.2 74,180 27.8 506,538 6,948 513,486
1See Technical Notes for a discussion of the impact of the 1993 AIDS surveillance case definition for adults and adolescents (implemented January 1, 1993)
on the number of cases reported annually since 1993.
2Totals include 2,252 persons whose area of residence is unknown.
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Table 3. AIDS cases by age group, exposure category, and sex, reported in 1994 and 1995; 1 and
cumulative totals, by age group and exposure category, through December 1995,
United States
 Males Females Totals 2
Cumulative
Adult/adolescent
1994 1995 1994 1995 1994 1995 total 3
exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 35,524 (55) 30,671 (51) – – – – 35,524 (45) 30,671 (42) 259,672 (51)
Injecting drug use 16,044 (25) 14,057 (24) 5,923 (43) 5,204 (38) 21,967 (28) 19,261 (26) 128,696 (25)
Men who have sex with men
and inject drugs 4,234 ( 7) 3,425 ( 6) – – – – 4,234 (5) 3,425 ( 5) 33,195 ( 7)
Hemophilia/coagulation disorder 483 ( 1) 423 ( 1) 25 ( 0) 22 ( 0) 508 ( 1) 445 ( 1) 4,107 ( 1)
Heterosexual contact: 3,009 ( 5) 2,840 ( 5) 5,575 (40) 5,253 (38) 8,585 (11) 8,093 (11) 40,038 ( 8)
Sex with injecting drug user 963 928 2,118 1,921 3,081 2,849 18,710
Sex with bisexual male – – 394 376 394 376 2,209
Sex with person with hemophilia 2 12 56 50 58 62 330
Sex with transfusion recipient
with HIV infection 66 53 63 59 129 112 734
Sex with HIV-infected person,
risk not specified 1,978 1,847 2,944 2,847 4,923 4,694 18,055
Receipt of blood transfusion,
blood components, or tissue4 405 ( 1) 366 ( 1) 329 ( 2) 298 ( 2) 734 ( 1) 664 ( 1) 7,433 ( 1)
Other/risk not reported
or identified5 5,276 ( 8) 7,834 (13) 2,035 (15) 2,987 (22) 7,311 ( 9) 10,821 (15) 33,397 ( 7)
Adult/adolescent subtotal 64,975 (100) 59,616 (100) 13,887 (100) 13,764 (100) 78,863 (100) 73,380 (100) 506,538 (100)
Pediatric (<13 years old)
exposure category
Hemophilia/coagulation disorder 14 ( 3) 5 ( 1) – – – – 14 ( 1) 5 ( 1) 227 ( 3)
Mother with/at risk for HIV infection:5 463 (91) 345 (89) 494 (94) 385 (93) 957 (93) 730 (91) 6,256 (90)
Injecting drug use 145 104 153 107 298 211 2,594
Sex with injecting drug user 73 59 75 55 148 114 1,164
Sex with bisexual male 10 6 9 4 19 10 128
Sex with person with hemophilia 2 – – 2 2 2 25
Sex with transfusion recipient
with HIV infection 3 – 2 2 5 2 26
Sex with HIV-infected person,
risk not specified 96 66 97 68 193 134 731
Receipt of blood transfusion,
blood components, or tissue 4 2 9 2 13 4 139
Has HIV infection, risk not specified 130 108 149 145 279 253 1,449
Receipt of blood transfusion,
blood components, or tissue4 23 ( 5) 17 ( 4) 17 ( 3) 9 ( 2) 40 ( 4) 26 ( 3) 366 ( 5)
Other/risk not reported or identified5 9 ( 2) 20 ( 5) 14 ( 3) 19 ( 5) 23 ( 2) 39 ( 5) 99 ( 1)
Pediatric subtotal 509 (100) 387 (100) 525 (100) 413 (100) 1,034 (100) 800 (100) 6,948 (100)
Total 65,484 60,003 14,412 14,177 79,897 74,180 513,486
1See Technical Notes for a discussion of the impact of the 1993 AIDS surveillance case definition for adults and adolescents (implemented January 1, 1993)
on the number of cases reported annually since 1993.
2Includes 1 person whose sex is unknown.
3Includes 9 persons known to be infected with human immunodeficiency virus type 2 (HIV-2). See MMWR 1995;44:603–06.
4Thirty-three adults/adolescents and 2 children developed AIDS after receiving blood screened negative for HIV antibody. Ten additional adults developed
AIDS after receiving tissue, organs, or artificial insemination from HIV-infected donors. Three of the 10 received tissue, organs, or artificial insemination
from a donor who was negative for HIV antibody at the time of donation. See N Engl J Med 1992;326:726-32.
5See Table 16 and Figure 7 for a discussion of the “other” exposure category. “Other” also includes 29 persons who acquired HIV infection perinatally but
were diagnosed with AIDS after age 13. These 29 persons are tabulated under the adult/adolescent, not pediatric, exposure category.
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Table 4. Male adult/adolescent AIDS cases by exposure category and race/ethnicity, reported in
1995, and cumulative totals, through December 1995, United States
White, not Hispanic Black, not Hispanic Hispanic
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 18,692 (71) 171,735 (76) 7,114 (34) 51,792 (39) 4,389 (39) 32,700 (44)
Injecting drug use 2,851 (11) 19,375 ( 9) 7,180 (34) 47,725 (36) 3,929 (35) 27,684 (38)
Men who have sex with men
and inject drugs 1,741 ( 7) 17,697 ( 8) 1,147 ( 5) 10,147 ( 8) 494 ( 4) 5,035 ( 7)
Hemophilia/coagulation disorder 313 ( 1) 3,161 ( 1) 61 ( 0) 400 ( 0) 40 ( 0) 329 ( 0)
Heterosexual contact: 545 ( 2) 2,925 ( 1) 1,553 ( 7) 7,472 ( 6) 715 ( 6) 3,023 ( 4)
Sex with injecting drug user 178 1,255 514 3,312 229 1,065
Sex with person with hemophilia 8 20 3 7 1 7
Sex with transfusion recipient
with HIV infection 21 117 22 100 8 66
Sex with HIV-infected person,
risk not specified 338 1,533 1,014 4,053 477 1,885
Receipt of blood transfusion,
blood components, or tissue 196 ( 1) 2,867 ( 1) 113 ( 1) 873 ( 1) 45 ( 0) 475 ( 1)
Risk not reported or identified1 2,170 ( 8) 6,890 ( 3) 4,016 (19) 13,061 (10) 1,525 (14) 4,453 ( 6)
Total 26,508 (100) 224,650 (100) 21,184 (100) 131,470 (100) 11,137 (100) 73,699 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals 2
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 331 (69) 2,434 (77) 104 (53) 671 (60) 30,671 (51) 259,672 (60)
Injecting drug use 34 ( 7) 154 ( 5) 39 (20) 157 (14) 14,057 (24) 95,244 (22)
Men who have sex with men
and inject drugs 14 ( 3) 101 ( 3) 27 (14) 191 (17) 3,425 ( 6) 33,195 ( 8)
Hemophilia/coagulation disorder 6 ( 1) 49 ( 2) 1 ( 1) 24 ( 2) 423 ( 1) 3,970 ( 1)
Heterosexual contact: 19 ( 4) 71 ( 2) 2 ( 1) 16 ( 1) 2,840 ( 5) 13,521 ( 3)
Sex with injecting drug user 4 22 1 7 928 5,664
Sex with person with hemophilia – – – – 12 34
Sex with transfusion recipient
with HIV infection 2 5 – 1 53 290
Sex with HIV-infected person,
risk not specified 13 44 1 8 1,847 7,533
Receipt of blood transfusion,
blood components, or tissue 10 ( 2) 95 ( 3) 2 ( 1) 6 ( 1) 366 ( 1) 4,327 ( 1)
Risk not reported or identified 63 (13) 245 ( 8) 23 (12) 50 ( 4) 7,834 (13) 24,790 ( 6)
Total 477 (100) 3,149 (100) 198 (100) 1,115 (100) 59,616 (100) 434,719 (100)
1See Figure 7.
2Includes 636 men whose race/ethnicity is unknown.
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Table 5. Female adult/adolescent AIDS cases by exposure category and race/ethnicity, reported in
1995, and cumulative totals, through December 1995, United States
White, not Hispanic Black, not Hispanic Hispanic
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Injecting drug use 1,229 (40) 7,441 (43) 2,920 (38) 19,200 (49) 1,018 (36) 6,603 (45)
Hemophilia/coagulation disorder 7 ( 0) 80 ( 0) 12 ( 0) 37 ( 0) 3 ( 0) 18 ( 0)
Heterosexual contact: 1,215 (39) 6,474 (38) 2,637 (34) 13,265 (34) 1,349 (47) 6,514 (44)
Sex with injecting drug user 462 2,912 886 6,413 559 3,615
Sex with bisexual male 153 1,024 143 796 70 332
Sex with person with hemophilia 33 223 9 44 8 24
Sex with transfusion recipient
with HIV infection 20 239 20 114 16 75
Sex with HIV-infected person,
risk not specified 547 2,076 1,579 5,898 696 2,468
Receipt of blood transfusion,
blood components, or tissue 104 ( 3) 1,644 (10) 133 ( 2) 910 ( 2) 51 ( 2) 462 ( 3)
Risk not reported or identified1 551 (18) 1,548 ( 9) 1,978 (26) 5,858 (15) 426 (15) 1,106 ( 8)
Total 3,106 (100) 17,187 (100) 7,680 (100) 39,270 (100) 2,847 (100) 14,703 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals 2
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Injecting drug use 17 (23) 67 (18) 12 (32) 91 (46) 5,204 (38) 33,452 (47)
Hemophilia/coagulation disorder – – 2 ( 1) – – – – 22 ( 0) 137 ( 0)
Heterosexual contact: 32 (43) 163 (44) 15 (39) 72 (37) 5,253 (38) 26,516 (37)
Sex with injecting drug user 4 48 8 43 1,921 13,046
Sex with bisexual male 7 46 3 9 376 2,209
Sex with person with hemophilia – 3 – 2 50 296
Sex with transfusion recipient
with HIV infection 2 14 – – 59 444
Sex with HIV-infected person,
risk not specified 19 52 4 18 2,847 10,521
Receipt of blood transfusion,
blood components, or tissue 8 (11) 77 (21) 1 ( 3) 11 ( 6) 298 ( 2) 3,106 ( 4)
Risk not reported or identified 17 (23) 58 (16) 10 (26) 23 (12) 2,987 (22) 8,607 (12)
Total 74 (100) 367 (100) 38 (100) 197 (100) 13,764 (100) 71,818 (100)
1See Figure 7.
2Includes 94 women whose race/ethnicity is unknown.
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Table 6. Pediatric AIDS cases by exposure category and race/ethnicity, reported in 1995, and
cumulative  totals, through December 1995, United States
White, not Hispanic Black, not Hispanic Hispanic
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hemophilia/coagulation disorder 4 ( 3) 156 (12) – – 32 ( 1) 1 ( 1) 35 ( 2)
Mother with/at risk for HIV infection: 102 (86) 918 (72) 449 (92) 3,792 (95) 169 (91) 1,487 (91)
Injecting drug use 33 393 126 1,549 51 633
Sex with injecting drug user 15 173 59 572 39 410
Sex with bisexual male 5 49 2 43 3 34
Sex with person with hemophilia – 15 – 5 2 5
Sex with transfusion recipient
with HIV infection 1 10 1 9 – 7
Sex with HIV-infected person,
risk not specified 21 95 77 471 33 155
Receipt of blood transfusion,
blood components, or tissue 1 40 2 70 1 28
Has HIV infection, risk not specified 26 143 182 1,073 40 215
Receipt of blood transfusion,
blood components, or tissue 10 ( 8) 182 (14) 7 ( 1) 83 ( 2) 9 ( 5) 91 ( 6)
Risk not reported or identified1 2 ( 2) 14 ( 1) 30 ( 6) 67 ( 2) 6 ( 3) 16 ( 1)
Total 118 (100) 1,270 (100) 486 (100) 3,974 (100) 185 (100) 1,629 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals 2
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hemophilia/coagulation disorder – – 3 ( 8) – – 1 ( 5) 5 ( 1) 227 ( 3)
Mother with/at risk for HIV infection: 4 (80) 25 (64) 2 (100) 20 (95) 730 (91) 6,256 (90)
Injecting drug use – 4 1 10 211 2,594
Sex with injecting drug user 1 3 – 4 114 1,164
Sex with bisexual male – 2 – – 10 128
Sex with person with hemophilia – – – – 2 25
Sex with transfusion recipient
with HIV infection – – – – 2 26
Sex with HIV-infected person,
risk not specified 2 6 – 1 134 731
Receipt of blood transfusion,
blood components, or tissue – 1 – – 4 139
Has HIV infection, risk not specified 1 9 1 5 253 1,449
Receipt of blood transfusion,
blood components, or tissue – – 9 (23) – – – – 26 ( 3) 366 ( 5)
Risk not reported or identified 1 (20) 2 ( 5) – – – – 39 ( 5) 99 ( 1)
Total 5 (100) 39 (100) 2 (100) 21 (100) 800 (100) 6,948 (100)
1See Figure 7, footnote 1.
2Includes 15 children whose race/ethnicity is unknown.
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Table 7. AIDS cases in adolescents and adults under age 25, by sex and exposure category, reported
in 1994 and 1995, 1 and cumulative totals through December 1995, United States
13-19 years old 20-24 years old
Cumulative Cumulative
1994 1995 total 1994 1995 total
Male exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 69 (29) 83 (34) 501 (33) 1,147 (62) 940 (58) 9,084 (63)
Injecting drug use 12 ( 5) 15 ( 6) 97 ( 6) 228 (12) 173 (11) 1,803 (13)
Men who have sex with men
and inject drugs 6 ( 3) 9 ( 4) 77 ( 5) 145 ( 8) 111 ( 7) 1,562 (11)
Hemophilia/coagulation disorder 103 (43) 81 (33) 646 (42) 66 ( 4) 66 ( 4) 539 ( 4)
Heterosexual contact: 9 ( 4) 7 ( 3) 38 ( 2) 86 ( 5) 113 ( 7) 505 ( 4)
Sex with injecting drug user 2 2 14 26 35 208
Sex with person with hemophilia – 1 1 – 2 3
Sex with transfusion recipient
with HIV infection – – – 2 2 11
Sex with HIV-infected person,
risk not specified 7 4 23 58 74 283
Receipt of blood transfusion,
blood components, or tissue 13 ( 5) 10 ( 4) 66 ( 4) 15 ( 1) 9 ( 1) 101 ( 1)
Risk not reported or identified2 26 (11) 40 (16) 109 ( 7) 167 ( 9) 220 (13) 802 ( 6)
Male subtotal 238 (100) 245 (100) 1,534 (100) 1,854 (100) 1,632 (100) 14,396 (100)
Female exposure category
Injecting drug use 18 (10) 11 ( 7) 132 (16) 187 (23) 152 (19) 1,430 (31)
Hemophilia/coagulation disorder 3 ( 2) 1 ( 1) 9 ( 1) – – 2 ( 0) 12 ( 0)
Heterosexual contact: 86 (48) 81 (51) 440 (54) 452 (56) 407 (51) 2,338 (51)
Sex with injecting drug user 29 22 197 160 136 1,159
Sex with bisexual male 3 5 23 22 29 183
Sex with person with hemophilia 3 2 12 10 6 44
Sex with transfusion recipient
with HIV infection – – 1 – 6 15
Sex with HIV-infected person,
risk not specified 51 52 207 260 230 937
Receipt of blood transfusion,
blood components, or tissue 11 ( 6) 7 ( 4) 60 ( 7) 6 ( 1) 13 ( 2) 105 ( 2)
Risk not reported or identified 61 (34) 60 (38) 179 (22) 169 (21) 226 (28) 674 (15)
Female subtotal 179 (100) 160 (100) 820 (100) 814 (100) 800 (100) 4,559 (100)
Total 2 417 405 2,354 2,668 2,432 18,955
1See Technical Notes for a discussion of the impact of the 1993 AIDS surveillance case definition for adults and adolescents (implemented January 1, 1993)
on the number of cases reported annually since 1993.
2See Figure 7.
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 Men who have Injecting  with men and coagulation Heterosexual
 sex with men  drug use  inject drugs disorder contact
Age at diagnosis (years) No. (%) No. (%) No. (%) No. (%) No. (%)
Under 5 – – – – – – 11 ( 0) – –
5-12 – – – – – – 216 ( 5) – –
13-19 501 ( 0) 229 ( 0) 77 ( 0) 655 (15) 478 ( 1)
20-24 9,084 ( 3) 3,233 ( 3) 1,562 ( 5) 551 (13) 2,843 ( 7)
25-29 40,634 (16) 14,193 (11) 6,273 (19) 647 (15) 7,162 (18)
30-34 62,947 (24) 29,483 (23) 9,491 (29) 613 (14) 8,894 (22)
35-39 56,247 (22) 35,309 (27) 8,066 (24) 502 (12) 7,278 (18)
40-44 39,840 (15) 26,076 (20) 4,449 (13) 386 ( 9) 4,816 (12)
45-49 24,003 ( 9) 11,747 ( 9) 1,981 ( 6) 276 ( 6) 3,081 ( 8)
50-54 13,125 ( 5) 4,887 ( 4) 793 ( 2) 152 ( 4) 2,138 ( 5)
55-59 7,262 ( 3) 2,154 ( 2) 323 ( 1) 104 ( 2) 1,427 ( 4)
60-64 3,791 ( 1) 888 ( 1) 122 ( 0) 102 ( 2) 918 ( 2)
65 or older 2,238 ( 1) 497 ( 0) 58 ( 0) 119 ( 3) 1,003 ( 3)
Total 259,672 (100) 128,696 (100) 33,195 (100) 4,334 (100) 40,038 (100)
 Mother with/ Other/risk not
Receipt of at risk for reported or
 transfusion HIV infection identified 1 Total
Age at diagnosis (years) No. (%) No. (%) No. (%) No. (%)
Under 5 141 ( 2) 5,319 (85) 55 ( 0) 5,526 ( 1)
5-12 225 ( 3) 937 (15) 44 ( 0) 1,422 ( 0)
13-19 126 ( 2) 29 ( 0) 259 ( 1) 2,354 ( 0)
20-24 206 ( 3) – – 1,476 ( 4) 18,955 ( 4)
25-29 541 ( 7) – – 4,523 (14) 73,973 (14)
30-34 757 (10) – – 6,713 (20) 118,898 (23)
35-39 782 (10) – – 6,194 (19) 114,378 (22)
40-44 747 (10) – – 4,686 (14) 81,000 (16)
45-49 587 ( 8) – – 3,208 (10) 44,883 ( 9)
50-54 621 ( 8) – – 2,315 ( 7) 24,031 ( 5)
55-59 623 ( 8) – – 1,682 ( 5) 13,575 ( 3)
60-64 751 (10) – – 1,148 ( 3) 7,720 ( 2)
65 or older 1,692 (22) – – 1,164 ( 3) 6,771 ( 1)
Total 7,799 (100) 6,285 (100) 33,467 (100) 513,486 (100)
1See Figure 7.
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Table 9. AIDS cases by sex, age at diagnosis, and race/ethnicity, reported through December 1995,
United States
 White, Black, Asian/Pacific American Indian/
not  Hispanic not  Hispanic Hispanic Islander Alaska Native Total 1
Male
Age at diagnosis (years) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Under 5 422 ( 0) 1,672 ( 1) 642 ( 1) 15 ( 0) 9 ( 1) 2,763 ( 1)
  5-12 295 ( 0) 299 ( 0) 207 ( 0) 8 ( 0) 1 ( 0) 812 ( 0)
13-19 687 ( 0) 503 ( 0) 311 ( 0) 18 ( 1) 14 ( 1) 1,534 ( 0)
20-24 6,338 ( 3) 4,945 ( 4) 2,936 ( 4) 105 ( 3) 48 ( 4) 14,396 ( 3)
25-29 31,240 (14) 18,071 (14) 11,636 (16) 416 (13) 228 (20) 61,674 (14)
30-34 53,033 (24) 29,132 (22) 18,016 (24) 694 (22) 302 (27) 101,309 (23)
35-39 50,448 (22) 30,676 (23) 16,567 (22) 679 (21) 233 (21) 98,758 (23)
40-44 36,500 (16) 22,587 (17) 11,299 (15) 555 (17) 153 (14) 71,200 (16)
45-49 21,626 (10) 12,054 ( 9) 6,140 ( 8) 316 (10) 71 ( 6) 40,265 ( 9)
50-54 11,606 ( 5) 6,465 ( 5) 3,208 ( 4) 174 ( 5) 30 ( 3) 21,514 ( 5)
55-59 6,429 ( 3) 3,578 ( 3) 1,840 ( 2) 102 ( 3) 18 ( 2) 11,997 ( 3)
60-64 3,699 ( 2) 1,938 ( 1) 1,010 ( 1) 42 ( 1) 11 ( 1) 6,709 ( 2)
65 or older 3,044 ( 1) 1,521 ( 1) 736 ( 1) 48 ( 2) 7 ( 1) 5,363 ( 1)
Male subtotal 225,367 (100) 133,441 (100) 74,548 (100) 3,172 (100) 1,125 (100) 438,294 (100)
Female
Age at diagnosis (years)
Under 5 424 ( 2) 1,685 ( 4) 626 ( 4) 10 ( 3) 11 ( 5) 2,763 ( 4)
  5-12 129 ( 1) 318 ( 1) 154 ( 1) 6 ( 2) – – 610 ( 1)
13-19 151 ( 1) 537 ( 1) 126 ( 1) 4 ( 1) 1 ( 0) 820 ( 1)
20-24 1,085 ( 6) 2,439 ( 6) 990 ( 6) 20 ( 5) 20 (10) 4,559 ( 6)
25-29 3,088 (17) 6,405 (16) 2,719 (18) 42 (11) 37 (18) 12,299 (16)
30-34 4,103 (23) 9,594 (23) 3,739 (24) 79 (21) 48 (23) 17,589 (23)
35-39 3,366 (19) 9,047 (22) 3,067 (20) 67 (17) 40 (19) 15,619 (21)
40-44 2,089 (12) 5,730 (14) 1,894 (12) 57 (15) 21 (10) 9,800 (13)
45-49 1,086 ( 6) 2,522 ( 6) 957 ( 6) 33 ( 9) 14 ( 7) 4,618 ( 6)
50-54 626 ( 4) 1,317 ( 3) 544 ( 4) 20 ( 5) 6 ( 3) 2,517 ( 3)
55-59 476 ( 3) 744 ( 2) 340 ( 2) 11 ( 3) 5 ( 2) 1,578 ( 2)
60-64 348 ( 2) 475 ( 1) 169 ( 1) 16 ( 4) 3 ( 1) 1,011 ( 1)
65 or older 769 ( 4) 460 ( 1) 158 ( 1) 18 ( 5) 2 ( 1) 1,408 ( 2)
Female subtotal 17,740 (100) 41,273 (100) 15,483 (100) 383 (100) 208 (100) 75,191 (100)
Total 2 243,107 174,715 90,031 3,555 1,333 513,486
1Includes 641 males and 104 females whose race/ethnicity is unknown.
2Includes 1 person whose sex is unknown.
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1992 1992 1993 1994 1995 total
Definition category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Pre-1987 definition 181,323 (71) 36,350 (47) 26,033 (34) 18,907 (30) 9,643 (24) 272,256 (53)
1987 definition 60,781 (24) 19,827 (26) 14,379 (19) 10,833 (17) 5,782 (14) 111,602 (22)
1993 definition1 14,873 ( 6) 20,721 (27) 35,122 (46) 34,286 (54) 24,626 (61) 129,628 (25)
Pulmonary tuberculosis 2,112 1,612 1,806 1,184 504 7,218
Recurrent pneumonia 532 562 1,071 853 473 3,491
Invasive cervical cancer 103 81 110 109 40 443
Severe HIV-related
immunosuppression2 12,171 18,494 32,173 32,169 23,617 118,624
Total 256,977 (100) 76,898 (100) 75,534 (100) 64,026 (100) 40,051 (100) 513,486 (100)
1Persons who meet only the 1993 AIDS case definition and whose date of diagnosis is before January 1993 were diagnosed retrospectively. The sum of
diagnoses listed for the four conditions under the 1993 definition do not equal the 1993 definition total because some persons have more than one
diagnosis from the added conditions of pulmonary tuberculosis, recurrent pneumonia, and invasive cervical cancer.
2Defined as CD4+ T-lymphocyte count of less than 200 cells/µL or a CD4+ percentage less than 14 in persons with laboratory confirmation of HIV infection.
Table 10. AIDS cases and annual rates per 100,000 population, by race/ethnicity, age group, and
sex, reported in 1995, United States
Adults/adolescents Children
Males Females Total <13 years old Total
 Race/ethnicity No. Rate No. Rate No. Rate No. Rate No. Rate
 White, not Hispanic 26,508 34.3 3,106 3.8 29,614 18.5 118 0.4 29,732 15.4
 Black, not Hispanic 21,184 190.3 7,680 59.2 28,864 119.7 486 6.4 29,350 92.6
 Hispanic 11,137 98.0 2,847 25.4 13,984 61.9 185 2.3 14,169 46.2
 Asian/Pacific Islander 477 14.0 74 2.0 551 7.8 5 0.3 556 6.2
 American Indian/Alaska Native 198 28.4 38 5.2 236 16.5 2 0.4 238 12.3
 Total 1 59,616 57.4 13,764 12.4 73,380 34.1 800 1.5 74,180 27.8
 1Totals include 135 persons whose race/ethnicity is unknown.
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Table 12. AIDS-indicator conditions reported in 1995, by age group, United States
Adults/ Children
adolescents <13 years old
AIDS-indicator conditions No. (%) 1 No. (%)1
Bacterial infections, multiple or recurrent NA2 123 (15)
Candidiasis of bronchi, trachea, or lungs 736 ( 1) 18 ( 2)
Candidiasis of esophagus
Definitive diagnosis 3,136 ( 4) 56 ( 7)
Presumptive diagnosis 2,286 ( 3) 69 ( 9)
Carcinoma, invasive cervical 166 ( 0) NA3
Coccidioidomycosis, disseminated or extrapulmonary 140 ( 0) – –
Cryptococcosis, extrapulmonary 1,626 ( 2) 7 ( 1)
Cryptosporidiosis, chronic intestinal 760 ( 1) 27 ( 3)
Cytomegalovirus disease other than retinitis 1,611 ( 2) 48 ( 6)
Cytomegalovirus retinitis
Definitive diagnosis 1,003 ( 1) 7 ( 1)
Presumptive diagnosis 491 ( 1) 1 ( 0)
Herpes simplex, with esophagitis, pneumonitis, or chronic mucocutaneous ulcers 1,927 ( 3) 46 ( 6)
Histoplasmosis, disseminated or extrapulmonary 309 ( 0) – –
HIV encephalopathy (dementia) 1,872 ( 3) 132 (17)
HIV wasting syndrome 6,618 ( 9) 146 (18)
Immunosuppression, severe HIV-related4 62,292 (85) NA3
Isosporiasis, chronic intestinal 39 ( 0) – –
Kaposi’s sarcoma
Definitive diagnosis 2,067 ( 3) 1 ( 0)
Presumptive diagnosis 662 ( 1) – –
Lymphoid interstitial pneumonia and/or pulmonary lymphoid hyperplasia
Definitive diagnosis NA2 45 ( 6)
Presumptive diagnosis NA2 102 (13)
Lymphoma, Burkitt’s (or equivalent term) 197 ( 0) 2 ( 0)
Lymphoma, immunoblastic (or equivalent term) 742 ( 1) 7 ( 1)
Lymphoma, primary in brain 277 ( 0) 3 ( 0)
Mycobacterium avium or M. kansasii, disseminated or extrapulmonary
Definitive diagnosis 1,745 ( 2) 41 ( 5)
Presumptive diagnosis 297 ( 0) 9 ( 1)
M. tuberculosis, disseminated or extrapulmonary
Definitive diagnosis 435 ( 1) 2 ( 0)
Presumptive diagnosis 90 ( 0) – –
M. tuberculosis, pulmonary
Definitive diagnosis 1,383 ( 2) NA3
Presumptive diagnosis 306 ( 0) NA3
Mycobacterial disease, other, disseminated or extrapulmonary
Definitive diagnosis 315 ( 0) 7 ( 1)
Presumptive diagnosis 90 ( 0) 4 ( 1)
Pneumocystis carinii pneumonia
Definitive diagnosis 8,654 (12) 143 (18)
Presumptive diagnosis 4,442 ( 6) 69 ( 9)
Pneumonia, recurrent
Definitive diagnosis 1,417 ( 2) NA3
Presumptive diagnosis 412 ( 1) NA3
Progressive multifocal leukoencephalopathy 327 ( 0) 4 ( 1)
Salmonella septicemia, recurrent 78 ( 0) NA5
Toxoplasmosis of brain
Definitive diagnosis 806 ( 1) 5 ( 1)
Presumptive diagnosis 744 ( 1) 4 ( 1)
1Percentages are based upon 73,380 adult/adolescent and 800 pediatric cases reported to CDC in 1995. The sum of percentages is greater than 100
because some patients have more than one condition.
2Not applicable as indicator of AIDS in adults/adolescents.
3Not applicable as indicator of AIDS in children.
4Defined as CD4+ T-lymphocyte count of less than 200 cells/µL or a CD4+ percentage less than 14 in adults/adolescents who meet the AIDS surveillance
case definition.
5Tabulated above in “bacterial infections, multiple or recurrent.”
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Table 13. AIDS cases, case-fatality rates, 1 and deaths, by half-year and age group, through
December 1995, United States
 Adults/adolescents Children <13 years old
Cases diagnosed Case-fatality Deaths occurring Cases diagnosed Case-fatality Deaths occurring
Half-year during interval rate during interval during interval rate during interval
Before 1981 87 90.8 30 8 75.0 1
1981 Jan.-June 104 90.4 37 10 80.0 2
July-Dec. 203 92.6 83 6 83.3 6
1982 Jan.-June 433 92.6 151 15 93.3 10
July-Dec. 727 91.9 295 16 87.5 4
1983 Jan.-June 1,341 94.5 526 32 100.0 14
July-Dec. 1,708 94.2 945 44 90.9 16
1984 Jan.-June 2,674 93.7 1,426 53 88.7 27
July-Dec. 3,499 93.7 2,020 64 85.9 24
1985 Jan.-June 5,131 92.6 2,870 110 81.8 47
July-Dec. 6,538 93.1 3,972 137 85.4 72
1986 Jan.-June 8,671 92.1 5,187 143 85.3 69
July-Dec. 10,220 92.5 6,703 197 78.2 97
1987 Jan.-June 13,515 91.2 7,805 228 79.4 121
July-Dec. 14,870 89.8 8,239 268 74.3 171
1988 Jan.-June 17,348 87.8 9,682 263 69.2 138
July-Dec. 17,819 87.7 11,041 346 67.1 179
1989 Jan.-June 20,875 84.7 12,709 367 65.4 173
July-Dec. 21,214 83.7 14,616 345 68.7 193
1990 Jan.-June 24,049 81.1 15,020 388 61.6 193
July-Dec. 23,521 79.4 15,990 399 56.1 199
1991 Jan.-June 28,031 75.8 17,012 402 55.2 173
July-Dec. 30,169 72.3 18,903 389 50.4 219
1992 Jan.-June 36,535 65.3 19,451 482 47.7 191
July-Dec. 39,452 59.9 20,651 429 50.6 223
1993 Jan.-June 40,888 48.0 20,714 423 43.0 251
July-Dec. 33,806 41.9 21,768 417 42.9 259
1994 Jan.-June 34,052 32.3 22,596 374 35.0 280
July-Dec. 29,307 23.8 22,937 293 30.7 237
1995 Jan.-June 27,009 15.2 20,774 208 13.5 227
July-Dec. 12,742 7.4 11,405 92 8.7 99
Total 2 506,538 62.4 315,928 6,948 56.4 3,921
1Case-fatality rates are calculated for each half-year by date of diagnosis. Each 6-month case-fatality rate is the number of deaths ever reported among
cases diagnosed in that period (regardless of the year of death), divided by the number of total cases diagnosed in that period, multiplied by 100. For
example, during the interval January through June 1982, AIDS was diagnosed in 433 adults/adolescents. Through December 1995, 401 of these 433 were
reported as dead. Therefore, the case fatality rate is 92.6 (401 divided by 433, multiplied by 100). The case-fatality rates shown here may be underestimates
because of incomplete reporting of deaths. Reported deaths are not necessarily caused by HIV-related disease.
2Death totals include 370 adults/adolescents and 6 children known to have died, but whose dates of death are unknown.
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Table 14. Deaths in persons with AIDS, by race/ethnicity, age at death, and sex, occurring in 1993
and 1994; and cumulative totals reported through December 1995, United States 1
Males Females Both sexes 3
Race/ethnicity Cumulative Cumulative Cumulative
and age at death 2 1993 1994 total 1993 1994 total 1993 1994 total
White, not Hispanic
Under 15 50 50 466 46 40 340 96 90 806
15-24 189 157 2,249 45 43 365 234 200 2,614
25-34 5,563 5,265 45,618 446 563 3,291 6,009 5,828 48,909
35-44 8,180 8,568 62,791 553 615 3,084 8,733 9,183 65,875
45-54 3,728 3,810 27,418 202 229 1,169 3,930 4,039 28,587
55 or older 1,352 1,366 11,798 129 126 1,346 1,481 1,492 13,144
All ages 19,062 19,216 150,540 1,421 1,616 9,614 20,483 20,832 160,154
Black, not Hispanic
Under 15 141 131 1,054 141 155 1,070 282 286 2,124
15-24 211 185 1,991 135 155 959 346 340 2,950
25-34 3,202 3,366 25,181 1,053 1,220 7,866 4,255 4,586 33,047
35-44 4,987 5,512 33,507 1,397 1,713 8,602 6,384 7,225 42,110
45-54 2,028 2,371 12,824 413 565 2,498 2,441 2,936 15,322
55 or older 819 968 5,434 184 247 1,220 1,003 1,215 6,654
All ages 11,388 12,533 80,107 3,323 4,055 22,253 14,711 16,588 102,361
Hispanic
Under 15 66 60 496 54 64 444 120 124 940
15-24 103 104 1,094 54 41 373 157 145 1,467
25-34 1,945 1,963 15,714 417 529 3,196 2,362 2,492 18,910
35-44 2,579 2,818 18,482 507 579 2,992 3,086 3,397 21,474
45-54 962 1,202 6,935 165 186 963 1,127 1,388 7,898
55 or older 399 461 2,819 76 84 462 475 545 3,281
All ages 6,054 6,608 45,598 1,273 1,483 8,443 7,327 8,091 54,041
Asian/Pacific Islander
Under 15 2 3 16 3 4 11 5 7 27
15-24 6 2 28 1 – 5 7 2 33
25-34 71 105 553 6 13 48 77 118 601
35-44 110 120 801 13 7 69 123 127 870
45-54 50 79 385 8 7 41 57 86 426
55 or older 17 27 161 4 3 31 21 30 192
All ages 256 336 1,945 34 34 207 290 370 2,152
American Indian/Alaska Native
Under 15 2 2 10 1 1 7 3 3 17
15-24 3 4 20 – – 2 3 4 22
25-34 46 40 260 4 7 39 50 47 299
35-44 43 47 226 4 8 28 47 55 254
45-54 14 13 73 – 1 7 15 14 80
55 or older 6 3 31 1 – 5 7 3 36
All ages 114 109 623 11 17 88 125 126 711
All racial/ethnic groups
Under 15 261 246 2,043 245 266 1,877 506 512 3,920
15-24 513 452 5,387 235 239 1,705 748 691 7,092
25-34 10,837 10,749 87,428 1,926 2,333 14,450 12,763 13,082 101,878
35-44 15,920 17,082 115,976 2,481 2,925 14,800 18,401 20,007 130,777
45-54 6,793 7,479 47,696 788 989 4,687 7,581 8,468 52,383
55 or older 2,599 2,829 20,278 394 461 3,067 2,993 3,290 23,345
All ages 36,923 38,837 279,190 6,069 7,213 40,658 42,992 46,050 319,849
1Data tabulations for 1993 and 1994 are based on date of death occurrence. Data for deaths occurring in 1995 are incomplete and not tabulated separately,
but are included in the cumulative totals. Tabulations for 1993 and 1994 may increase as additional deaths are reported to CDC.
2Data tabulated under “all ages” include 454 persons whose age at death is unknown. Data tabulated under “all racial/ethnic groups” include 430 persons
whose race/ethnicity is unknown.
3Includes 1 person whose sex is unknown.
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Table 15. Adult/adolescent AIDS cases among Hispanics, by exposure category and place of birth,
reported in 1995, United States
Place of birth
Central/South
United States 1 America Cuba Mexico Puerto Rico T otals 2
Adult/adolescent
exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 1,721 (39) 404 (51) 234 (51) 554 (54) 653 (16) 4,389 (31)
Injecting drug use 1,474 (33) 29 (4) 39 ( 9) 91 ( 9) 2,083 (49) 4,947 (35)
Men who have sex with men
and inject drugs 219 ( 5) 14 ( 2) 8 ( 2) 32 ( 3) 155 ( 4) 494 ( 4)
Heterosexual contact 477 (11) 123 (15) 36 ( 8) 116 (11) 920 (22) 2,064 (15)
Hemophilia/coagulation
disorder or receipt of
blood transfusion, blood
components, or tissue 47 ( 1) 8 ( 1) 5 ( 1) 23 ( 2) 38 ( 1) 139 ( 1)
Risk not reported or identified3 486 (11) 217 (27) 133 (29) 211 (21) 360 ( 9) 1,951 (14)
Total 4,424 (100) 795 (100) 455 (100) 1,027 (100) 4,209 (100) 13,984 (100)
1Excludes persons born in U.S. dependencies, possessions, and independent nations in free association with the United States. Ancestry data for
U.S.-born Hispanics are not collected.
2Includes 376 persons born in locations other than those listed, and 2,698 persons whose place of birth is unknown.
3See Figure 7.
Table 16. Health care workers with documented and possible occupationally acquired AIDS/HIV
infection, by occupation, reported through December 1995, United States 1
Documented Possible
 occupational transmission 2 occupational transmission 3
Occupation No. No.
Dental worker, including dentist – 7
Embalmer/morgue technician – 3
Emergency medical technician/paramedic – 9
Health aide/attendant 1 12
Housekeeper/maintenance worker 1 7
Laboratory technician, clinical 15 15
Laboratory technician, nonclinical 3 0
Nurse 19 24
Physician, nonsurgical 6 10
Physician, surgical – 4
Respiratory therapist 1 2
Technician, dialysis 1 2
Technician, surgical 2 1
Technician/therapist, other than those listed above – 4
Other health care occupations – 2
Total 49 102
1Health care workers are defined as those persons, including students and trainees, who have worked in a health care, clinical, or HIV laboratory setting at
any time since 1978. See MMWR 1992;41:823-25.
2Health care workers who had documented HIV seroconversion after occupational exposure or had other laboratory evidence of occupational infection: 42
had percutaneous exposure, 5 had mucocutaneous exposure, 1 had both percutaneous and mucocutaneous exposures, and 1 had an unknown route of
exposure. Forty-four exposures were to blood from an HIV-infected person, 1 to visibly bloody fluid, 1 to an unspecified fluid, and 3 to concentrated virus in
a laboratory. Twenty-two of these health care workers developed AIDS.
3These health care workers have been investigated and are without identifiable behavioral or transfusion risks; each reported percutaneous or mucocutaneous
occupational exposures to blood or body fluids, or laboratory solutions containing HIV, but HIV seroconversion specifically resulting from an occupational
exposure was not documented.
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Table 17. Adult/adolescent AIDS cases by single and multiple exposure categories, reported
through December 1995, United States
AIDS cases
Exposure category No. (%)
Single mode of exposure
Men who have sex with men 249,680 (49)
Injecting drug use 105,245 (21)
Hemophilia/coagulation disorder 3,250 ( 1)
Heterosexual contact 38,830 ( 8)
Receipt of transfusion1 7,423 ( 1)
Receipt of transplant of tissues, organs, or artificial insemination2 10 ( 0)
Other3 58 ( 0)
Single mode of exposure subtotal 404,496 (80)
Multiple modes of exposure
Men who have sex with men; injecting drug use 28,959 ( 6)
Men who have sex with men; hemophilia/coagulation disorder 130 ( 0)
Men who have sex with men; heterosexual contact 6,492 ( 1)
Men who have sex with men; receipt of transfusion/transplant 3,086 ( 1)
Injecting drug use; hemophilia/coagulation disorder 166 ( 0)
Injecting drug use; heterosexual contact 21,046 ( 4)
Injecting drug use; receipt of transfusion/transplant 1,434 ( 0)
Hemophilia/coagulation disorder; heterosexual contact 66 ( 0)
Hemophilia/coagulation disorder; receipt of transfusion/transplant 765 ( 0)
Heterosexual contact; receipt of transfusion/transplant 1,208 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder 36 ( 0)
Men who have sex with men; injecting drug use; heterosexual contact 3,524 ( 1)
Men who have sex with men; injecting drug use; receipt of transfusion/transplant 523 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact 14 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; receipt of transfusion/transplant 32 ( 0)
Men who have sex with men; heterosexual contact; receipt of transfusion/transplant 234 ( 0)
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact 39 ( 0)
Injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 30 ( 0)
Injecting drug use; heterosexual contact; receipt of transfusion/transplant 721 ( 0)
Hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 26 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact 8 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; receipt of transfusion/transplant 13 ( 0)
Men who have sex with men; injecting drug use; heterosexual contact; receipt of transfusion/transplant 130 ( 0)
Men who have sex with men; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 4 ( 0)
Injecting drug use; hemophilia/coagulation disorder; heterosexual contact; receipt of transfusion/transplant 15 ( 0)
Men who have sex with men; injecting drug use; hemophilia/coagulation disorder; heterosexual contact;
  receipt of transfusion/transplant 2 ( 0)
Multiple modes of exposure subtotal 68,703 (14)
Risk not reported or identified 4 33,339 ( 7)
Total 506,538 (100)
1Includes 33 adult/adolescents who developed AIDS after receiving blood screened negative for HIV antibody.
2Ten adults developed AIDS after receiving tissue, organs, or artificial insemination from HIV-infected donors. Three of the 10 received tissue or organs from
a donor who was negative for HIV antibody at the time of donation. See N Engl J Med 1992;326:726-32.
3See Table 16 and Figure 7 for a discussion of the “other” exposure category. “Other” also includes 29 persons who acquired HIV infection perinatally, but
were diagnosed with AIDS after age 13.
4See Figure 7.










Figure 1. Male adult/adolescent AIDS annual rates per 100,000 population, for cases reported
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Figure 7. Results of investigations of adult/adolescent AIDS cases ever classified as risk not reported























































1Excludes 99 children under 13 years of age classified as “other/risk not reported or identified” in Table 3; 97 whose risk is not identified and 2 who were
exposed to HIV-infected blood in a household setting, as supported by seroconversion, epidemiologic, and/or laboratory evidence (see MMWR 1992;41:228-31
and N Engl J Med 1993;329:1835-41). An additional 333 children who were initially reported without risk information have been reclassified after investigation.
2Cases associated with persons born in Pattern-II countries are no longer classified as heterosexual transmission. See Technical Notes.
3Investigations of these persons included patient interviews. Based on available information, these persons could not be reclassified into an exposure
category. This group includes persons possibly infected through heterosexual contact with a partner who is not known to be HIV infected or at high risk for
HIV infection; persons who may choose not to disclose high-risk information; and persons with possible occupational exposure. These 862 persons report
heterosexual contact, sexually transmitted disease infections, non-injecting drug use, hepatitis infections, and occupational exposures to blood or body
fluids.
4Fifty-eight adult/adolescents are included in the “other” exposure category listed here and in Table 3, and were exposed to HIV-infected blood, body fluids,
or concentrated virus in health care, laboratory, or household settings, as supported by seroconversion, epidemiologic, and/or laboratory evidence. See
Table 16, MMWR 1993;42:329-31, and MMWR 1993;42:948-51. One person was infected following intentional self-inoculation of blood from an HIV-
infected person. Twenty-nine persons acquired HIV infection perinatally and were diagnosed with AIDS after age 13.
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Table 18. Estimated AIDS-opportunistic illness incidence, by region of residence and year of
diagnosis, 1990 through 1994, United States 1
Year of diagnosis
Region of residence 2 1990 1991 1992 1993 1994
Northeast 13,800 15,500 17,000 18,300 18,800
Midwest 4,500 5,500 6,200 6,200 6,400
South 14,900 17,300 20,000 20,300 22,600
West 10,500 12,200 12,900 12,300 13,000
Territories 1,700 2,000 2,100 2,200 2,000
Total 3 45,600 52,400 58,200 59,300 62,800
1Estimates are adjusted for delays in the reporting of AIDS cases, but not for incomplete reporting of cases. Estimates are rounded to the nearest 100.
Opportunistic illness refers to AIDS-defining opportunistic illnesses included in the 1993 AIDS surveillance case definition. See Technical Notes.
2See Technical Notes for a list of states or dependencies and possessions which comprise each region of residence.
3The sum of the regional estimates may not equal the total annual estimates because of rounding.
Table 19. Estimated AIDS-opportunistic illness incidence, by race/ethnicity and year of diagnosis,
1990 through 1994, United States 1
Year of diagnosis
Race/ethnicity 1990 1991 1992 1993 1994
White, not Hispanic 22,500 25,100 26,400 25,300 26,000
Black, not Hispanic 14,600 17,300 20,800 22,400 24,400
Hispanic 8,000 9,400 10,300 10,900 11,600
Asian/Pacific Islander 300 360 420 440 480
American Indian/Alaska Native 110 140 160 170 200
Total 2 45,600 52,400 58,200 59,300 62,800
1Estimates are adjusted for delays in the reporting of AIDS cases, but not for incomplete reporting of cases. Estimates of less than 200, 200 to 499, 500 to
999, and 1,000 or more are rounded to the nearest 10, 20, 50, and 100, respectively. See Technical Notes.
2Totals include estimates of persons whose race/ethnicity is unknown. The sum of race/ethnicity estimates may not equal the total annual estimates
because of rounding.
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Table 20. Estimated AIDS-opportunistic illness incidence, by age group, sex, exposure category,
and year of diagnosis, 1990 through 1994, United States 1
Year of diagnosis
Male adult/adolescent
exposure category 1990 1991 1992 1993 1994
Men who have sex with men 25,100 28,300 29,700 29,000 30,700
Injecting drug use 8,700 10,100 11,800 12,500 13,100
Men who have sex with men
and inject drugs 3,200 3,600 3,800 3,500 3,500
Hemophilia/coagulation disorder 340 380 440 440 420
Heterosexual contact 1,100 1,500 2,100 2,500 2,900
Receipt of blood transfusion,
blood components, or tissue 440 460 420 360 400
Risk not reported or identified 340 380 420 360 240
Male subtotal 39,200 44,600 48,800 48,800 51,300
Female adult/adolescent
exposure category
Injecting drug use 3,000 3,700 4,300 4,600 4,800
Hemophilia/coagulation disorder 10 20 20 20 30
Heterosexual contact 2,200 2,900 3,700 4,600 5,400
Receipt of blood transfusion,
blood components, or tissue 320 320 320 320 380
Risk not reported or identified 110 180 180 130 100
Female subtotal 5,600 7,000 8,500 9,700 10,700
Pediatric (<13 years old)
exposure category 2 800 800 950 900 800
Total 3 45,600 52,400 58,200 59,300 62,800
1Estimates are adjusted for delays in the reporting of AIDS cases and anticipated redistribution of cases initially reported with no identified risk, but not for
incomplete reporting of cases. Adult/adolescent and total estimates of less than 200, 200 to 499, 500 to 999, and 1,000 or more are rounded to the nearest
10, 20, 50, and 100, respectively. Pediatric estimates are rounded to the nearest 10. Opportunistic illness refers to AIDS-defining opportunistic illnesses
included in the 1993 AIDS surveillance case definition. See Technical Notes.
2Estimates are based on cases diagnosed using the 1987 definition, adjusted for reporting delays. The 1993 AIDS surveillance case definition affected only
adult/adolescent cases, not pediatric cases.
3The sum of the exposure category estimates may not equal the subtotal and total annual estimates because of rounding.
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Table 21. HIV infection cases (not AIDS) by state, reported in 1995; and cumulative totals, by
state and age group, through December 1995, from states with confidential HIV
infection reporting
Cumulative totals
State of residence Adults/ Children
(Date HIV reporting initiated) 1995 adolescents <13 years old Total
Alabama (Jan. 1988) 613 3,935 35 3,970
Arizona (Jan. 1987) 422 3,228 31 3,259
Arkansas (July 1989) 306 1,374 20 1,394
Colorado (Nov. 1985) 405 5,226 26 5,252
Connecticut (July 1992)1 8 – 74 74
Idaho (June 1986) 27 217 1 218
Indiana (July 1988) 429 2,666 21 2,687
Louisiana (Feb. 1993) 1,050 4,064 54 4,118
Michigan (April 1992) 1,036 3,099 85 3,184
Minnesota (Oct. 1985) 250 2,062 23 2,085
Mississippi (Aug. 1988) 594 3,063 37 3,100
Missouri (Oct. 1987) 651 3,390 39 3,429
Nebraska (Sept. 1995) 121 127 2 129
Nevada (Feb. 1992) 396 1,978 19 1,997
New Jersey (Jan. 1992) 2,565 10,475 301 10,776
North Carolina (Feb. 1990) 1,526 6,190 70 6,260
North Dakota (Jan. 1988) 1 47 – 47
Ohio (June 1990) 575 3,222 38 3,260
Oklahoma (June 1988) 193 1,603 11 1,614
South Carolina (Feb. 1986) 790 5,551 88 5,639
South Dakota (Jan. 1988) 25 152 5 157
Tennessee (Jan. 1992) 1,020 3,398 41 3,439
Texas (Feb. 1994)1 54 – 211 211
Utah (April 1989) 82 782 5 787
Virginia (July 1989) 1,297 6,030 56 6,086
West Virginia (Jan. 1989) 76 372 1 373
Wisconsin (Nov. 1985) 298 1,914 27 1,941
Wyoming (June 1989) 7 55 – 55
Subtotal 14,817 74,220 1,321 75,541
Persons reported from states with confidential
HIV reporting who were residents of other states2 393 1,732 29 1,761
Total 15,210 75,952 1,350 77,302
1Connecticut and Texas have confidential HIV infection reporting for pediatric cases only.
2Includes 325 persons reported from states with confidential HIV infection reporting, but whose state of residence is unknown. See Technical Notes.
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Table 22. Male adult/adolescent HIV infection cases (not AIDS) by exposure category and
race/ethnicity, reported in 1995, and cumulative totals through December 1995, from
states with confidential HIV infection reporting 1
White, not Hispanic Black, not Hispanic Hispanic
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 2,552 (60) 15,678 (60) 1,603 (30) 8,354 (31) 195 (30) 1,184 (35)
Injecting drug use 427 (10) 2,349 ( 9) 1,109 (21) 5,881 (22) 191 (29) 981 (29)
Men who have sex with men
and inject drugs 254 ( 6) 2,163 ( 8) 196 ( 4) 1,379 ( 5) 40 ( 6) 224 ( 7)
Hemophilia/coagulation disorder 57 ( 1) 325 ( 1) 18 ( 0) 73 ( 0) – – 7 ( 0)
Heterosexual contact: 110 ( 3) 634 ( 2) 473 ( 9) 2,229 ( 8) 55 ( 8) 177 ( 5)
Sex with an injecting drug user 36 188 126 586 17 67
Sex with person with hemophilia 1 4 – 6 – –
Sex with transfusion recipient
with HIV infection – 17 8 34 – 1
Sex with HIV-infected person,
risk not specified 73 425 339 1,603 38 109
Receipt of blood transfusion,
blood components, or tissue 24 ( 1) 172 ( 1) 34 ( 1) 140 ( 1) 3 ( 0) 20 ( 1)
Risk not reported or identified2 857 (20) 4,695 (18) 1,939 (36) 8,632 (32) 166 (26) 766 (23)
Total 4,281 (100) 26,016 (100) 5,372 (100) 26,688 (100) 650 (100) 3,359 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals 3
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Men who have sex with men 13 (52) 78 (51) 20 (47) 153 (49) 4,442 (42) 25,708 (44)
Injecting drug use 1 (4) 13 ( 8) 8 (19) 51 (16) 1,750 (16) 9,352 (16)
Men who have sex with men
and inject drugs – – 3 ( 2) 5 (12) 48 (15) 500 ( 5) 3,845 ( 7)
Hemophilia/coagulation disorder – – 3 ( 2) – – 3 ( 1) 79 ( 1) 417 ( 1)
Heterosexual contact: 2 ( 8) 6 ( 4) 1 ( 2) 12 ( 4) 645 ( 6) 3,086 ( 5)
Sex with an injecting drug user 1 3 1 3 182 855
Sex with person with hemophilia – – – – 1 10
Sex with transfusion recipient
with HIV infection – – – – 8 52
Sex with HIV-infected person,
risk not specified 1 3 – 9 454 2,169
Receipt of blood transfusion,
blood components, or tissue 1 ( 4) 3 ( 2) – – 3 ( 1) 63 ( 1) 345 ( 1)
Risk not reported or identified2 8 (32) 48 (31) 9 (21) 42 (13) 3,190 (30) 15,286 (26)
Total 25 (100) 154 (100) 43 (100) 312 (100) 10,669 (100) 58,039 (100)
1See Table 21 for states with confidential HIV infection reporting.
2For HIV infection cases (not AIDS), “risk not reported or identified” refers primarily to persons whose mode of exposure was not reported and who have not
been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
3Includes 1,510 men whose race/ethnicity is unknown.
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Table 23. Female adult/adolescent HIV infection cases (not AIDS) by exposure category and
race/ethnicity, reported in 1995, and cumulative totals through December 1995, from
states with confidential HIV infection reporting 1
White, not Hispanic Black, not Hispanic Hispanic
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Injecting drug use 244 (26) 1,354 (30) 564 (19) 2,888 (24) 62 (26) 299 (29)
Hemophilia/coagulation disorder 2 ( 0) 8 ( 0) – – 6 ( 0) – – – –
Heterosexual contact: 347 (37) 1,724 (38) 977 (34) 4,127 (35) 105 (44) 422 (40)
Sex with an injecting drug user 135 665 305 1,331 50 192
Sex with a bisexual male 40 220 60 309 3 19
Sex with person with hemophilia 6 46 3 25 2 6
Sex with transfusion recipient
with HIV-infection 3 22 4 30 – 3
Sex with HIV-infected person,
risk not specified 163 771 605 2,432 50 202
Receipt of blood transfusion,
blood components, or tissue 13 ( 1) 110 ( 2) 52 ( 2) 202 ( 2) 3 ( 1) 20 ( 2)
Risk not reported or identified2 341 (36) 1,298 (29) 1,300 (45) 4,659 (39) 70 (29) 307 (29)
Total 947 (100) 4,494 (100) 2,893 (100) 11,882 (100) 240 (100) 1,048 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals 3
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Injecting drug use – – 5 (11) 12 (38) 44 (40) 891 (21) 4,617 (26)
Hemophilia/coagulation disorder – – – – – – – – 2 ( 0) 14 ( 0)
Heterosexual contact: 6 (55) 20 (43) 11 (34) 41 (37) 1,454 (35) 6,369 (36)
Sex with an injecting drug user 2 8 7 24 500 2,227
Sex with a bisexual male – – 1 6 105 556
Sex with person with hemophilia – – – – 11 77
Sex with transfusion recipient
with HIV infection – – – – 7 55
Sex with HIV-infected person,
risk not specified 4 12 3 11 831 3,454
Receipt of blood transfusion,
blood components, or tissue 1 ( 9) 1 ( 2) 1 ( 3) 1 ( 1) 71 ( 2) 340 ( 2)
Risk not reported or identified2 4 (36) 20 (43) 8 (25) 24 (22) 1,777 (42) 6,557 (37)
Total 11 (100) 46 (100) 32 (100) 110 (100) 4,195 (100) 17,897 (100)
1See Table 21 for states with confidential HIV infection reporting.
2For HIV infection cases (not AIDS), “risk not reported or identified” refers primarily to persons whose mode of exposure was not reported and who have not
been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
3Includes 317 women whose race/ethnicity is unknown.
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Table 24. Pediatric HIV infection cases (not AIDS) by exposure category and race/ethnicity, reported
in 1995, and cumulative totals through December 1995, from states with confidential HIV
infection reporting 1
White, not Hispanic Black, not Hispanic Hispanic
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hemophilia/coagulation disorder 13 (15) 70 (20) 6 ( 3) 25 ( 3) 1 ( 3) 8 ( 5)
Mother with/at risk for HIV infection: 64 (76) 235 (69) 195 (89) 732 (90) 28 (88) 135 (85)
Injecting drug use 13 60 52 207 5 36
Sex with injecting drug user 12 39 20 78 4 26
Sex with bisexual male 1 2 3 11 – 1
Sex with person with hemophilia 2 2 – 2 – –
Sex with transfusion recipient
with HIV infection 2 4 – 1 – –
Sex with HIV-infected person,
risk not specified 15 41 47 119 6 20
Receipt of blood transfusion,
blood components, or tissue – 3 2 5 1 2
Has HIV infection, risk not specified 19 84 71 309 12 50
Receipt of blood transfusion,
blood components, or tissue 2 ( 2) 21 ( 6) 2 ( 1) 7 ( 1) 1 ( 3) 5 ( 3)
Risk not reported or identified2 5 ( 6) 16 ( 5) 17 ( 8) 51 ( 6) 2 ( 6) 10 ( 6)
Total 84 (100) 342 (100) 220 (100) 815 (100) 32 (100) 158 (100)
Asian/Pacific Islander American Indian/Alaska Native Cumulative totals 3
Cumulative Cumulative Cumulative
1995 total 1995 total 1995 total
Exposure category No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Hemophilia/coagulation disorder – – 1 (20) – – 2 (17) 20 ( 6) 109 ( 8)
Mother with/at risk for HIV infection: – – 1 (20) – – 8 (67) 291 (85) 1,118 (83)
Injecting drug use – – – 3 72 310
Sex with injecting drug user – – – 2 36 145
Sex with bisexual male – 1 – – 5 16
Sex with person with hemophilia – – – 1 2 5
Sex with transfusion recipient
with HIV infection – – – – 2 5
Sex with HIV-infected person,
risk not specified – – – – 68 180
Receipt of blood transfusion,
blood components, or tissue – – – – 3 10
Has HIV infection, risk not specified – – – 2 103 447
Receipt of blood transfusion,
blood components, or tissue – – – – – – – – 6 ( 2) 34 ( 3)
Risk not reported or identified – – 3 (60) – – 2 (17) 25 ( 7) 89 ( 7)
Total – – 5 (100) – – 12 (100) 342 (100) 1,350 (100)
1See Table 21 for states with confidential HIV infection reporting.
2For HIV infection cases (not AIDS), “risk not reported or identified” refers primarily to persons whose mode of exposure was not reported and who have not
been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
3Includes 18 children whose race/ethnicity is unknown.
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Table 25. HIV infection cases (not AIDS) in adolescents and adults under age 25, by sex and
exposure category, reported in 1995, and cumulative totals through December 1995,
from states with confidential HIV infection reporting 1
13-19 years old 20-24 years old
Cumulative Cumulative
1995 total 1995 total
Male exposure category No. (%)  No. (%) No. (%) No. (%)
Men who have sex with men 120 (47) 636 (44) 660 (54) 4,413 (53)
Injecting drug use 8 ( 3) 78 ( 5) 49 ( 4) 495 ( 6)
Men who have sex with men
and inject drugs 11 ( 4) 86 ( 6) 58 ( 5) 560 ( 7)
Hemophilia/coagulation disorder 25 (10) 106 ( 7) 14 ( 1) 90 ( 1)
Heterosexual contact: 9 ( 4) 90 ( 6) 69 ( 6) 448 ( 5)
Sex with an injecting drug user 1 17 15 92
Sex with person with hemophilia – 1 1 2
Sex with transfusion recipient
with HIV infection – 1 1 5
Sex with HIV-infected person,
risk not specified 8 71 52 349
Receipt of blood transfusion,
blood components, or tissue 1 ( 0) 10 ( 1) 3 ( 0) 37 ( 0)
Risk not reported or identified2 80 (31) 453 (31) 366 (30) 2,225 (27)
Male subtotal 254 (100) 1,459 (100) 1,219 (100) 8,268 (100)
Female exposure category
Injecting drug use 15 ( 5) 112 ( 8) 79 (12) 463 (14)
Hemophilia/coagulation disorder – – – – – – 2 ( 0)
Heterosexual contact: 116 (39) 605 (44) 243 (36) 1,295 (40)
Sex with an injecting drug user 25 146 56 375
Sex with a bisexual male 9 45 17 132
Sex with person with hemophilia 1 10 3 26
Sex with transfusion recipient
with HIV infection – 4 2 11
Sex with HIV-infected person,
risk not specified 81 400 165 751
Receipt of blood transfusion,
blood components, or tissue 4 ( 1) 11 ( 1) 6 ( 1) 31 ( 1)
Risk not reported or identified 166 (55) 652 (47) 354 (52) 1,409 (44)
Female subtotal 301 (100) 1,380 (100) 682 (100) 3,200 (100)
Total 3 555 2,840 1,902 11,470
1See Table 21 for states with confidential HIV infection reporting.
2For HIV infection cases (not AIDS), “risk not reported or identified” refers primarily to persons whose mode of exposure was not reported and who have not
been followed up to determine their mode of exposure, and to a smaller number of persons who are not reported with one of the exposures listed above
after follow-up. See Technical Notes.
3Includes 3 persons whose sex is unknown.
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Table 26. HIV infection cases (not AIDS), by sex, age at diagnosis, and race/ethnicity, reported
through December 1995, from states with confidential HIV infection reporting 1
 White, Black, Asian/Pacific American Indian/
not  Hispanic not  Hispanic Hispanic Islander Alaska Native Total 2
Male
Age at diagnosis (years) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Under 5 119 ( 0) 344 ( 1) 61 ( 2) 2 ( 1) 3 ( 1) 533 ( 1)
  5-12 78 ( 0) 66 ( 0) 19 ( 1) – – 2 ( 1) 172 ( 0)
13-19 585 ( 2) 778 ( 3) 53 ( 2) 4 ( 3) 8 ( 3) 1,459 ( 2)
20-24 3,867 (15) 3,691 (14) 437 (13) 28 (18) 59 (19) 8,268 (14)
25-29 6,691 (26) 5,662 (21) 869 (25) 39 (25) 93 (29) 13,697 (23)
30-34 6,312 (24) 5,977 (22) 845 (25) 39 (25) 70 (22) 13,609 (23)
35-39 4,076 (16) 5,030 (19) 594 (17) 19 (12) 45 (14) 10,037 (17)
40-44 2,272 ( 9) 3,054 (11) 319 ( 9) 12 ( 8) 20 ( 6) 5,826 (10)
45-49 1,131 ( 4) 1,299 ( 5) 144 ( 4) 8 ( 5) 9 ( 3) 2,675 ( 5)
50-54 567 ( 2) 644 ( 2) 47 ( 1) 2 ( 1) 5 ( 2) 1,302 ( 2)
55-59 254 ( 1) 275 ( 1) 23 ( 1) 1 ( 1) 2 ( 1) 568 ( 1)
60-64 135 ( 1) 147 ( 1) 16 ( 0) – – 1 ( 0) 308 ( 1)
65 or older 126 ( 0) 131 ( 0) 12 ( 0) 2 ( 1) – – 290 ( 0)
Male subtotal 26,213 (100) 27,098 (100) 3,439 (100) 156 (100) 317 (100) 58,744 (100)
Female
Age at diagnosis (years)
Under 5 120 ( 3) 342 ( 3) 63 ( 6) 2 ( 4) 6 ( 5) 538 ( 3)
  5-12 25 ( 1) 63 ( 1) 15 ( 1) 1 ( 2) 1 ( 1) 107 ( 1)
13-19 284 ( 6) 1,008 ( 8) 59 ( 5) 1 ( 2) 10 ( 9) 1,380 ( 7)
20-24 862 (19) 2,105 (17) 155 (14) 10 (20) 19 (16) 3,200 (17)
25-29 1,089 (23) 2,653 (22) 283 (25) 16 (33) 20 (17) 4,135 (22)
30-34 976 (21) 2,541 (21) 270 (24) 11 (22) 27 (23) 3,896 (21)
35-39 652 (14) 1,826 (15) 128 (11) 2 ( 4) 20 (17) 2,673 (14)
40-44 276 ( 6) 961 ( 8) 81 ( 7) 3 ( 6) 12 (10) 1,361 ( 7)
45-49 175 ( 4) 386 ( 3) 37 ( 3) 2 ( 4) 2 ( 2) 618 ( 3)
50-54 62 ( 1) 182 ( 1) 18 ( 2) 1 ( 2) – – 269 ( 1)
55-59 46 ( 1) 111 ( 1) 12 ( 1) – – – – 171 ( 1)
60-64 22 ( 0) 50 ( 0) 5 ( 0) – – – – 78 ( 0)
65 or older 50 ( 1) 59 ( 0) – – – – – – 116 ( 1)
Female subtotal 4,639 (100) 12,287 (100) 1,126 (100) 49 (100) 117 (100) 18,542 (100)
Total 3 30,852 39,388 4,565 205 434 77,302
1See Table 21 for states with confidential HIV infection reporting.
2Includes 1,521 males, 324 females, and 13 persons with unknown sex whose race/ethnicity is unknown.
3Includes 16 persons whose sex is unknown.
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Table 27. Persons reported to be living with HIV infection (not AIDS) and with AIDS, by state and
age group, reported through December 1995 1
Living with HIV (not AIDS) 2 Living with AIDS 3 Cumulative totals
State of residence Children Children Children
(Date HIV reporting Adults/ <13 years Adults/ <13 years Adults/ <13 years
 initiated) adolescents old Total adolescents old Total adolescents old Total
Alabama (Jan. 1988) 3,824 35 3,859 1,583 17 1,600 5,407 52 5,459
Alaska – – – 150 1 151 150 1 151
Arizona (Jan. 1987) 2,886 27 2,913 1,494 7 1,501 4,380 34 4,414
Arkansas (July 1989) 1,350 20 1,370 924 15 939 2,274 35 2,309
California – – – 30,377 179 30,556 30,377 179 30,556
Colorado (Nov. 1985) 4,915 25 4,940 2,066 8 2,074 6,981 33 7,014
Connecticut (July 1992)4 – 66 66 3,597 75 3,672 3,597 141 3,738
Delaware – – – 635 5 640 635 5 640
District of Columbia – – – 3,245 58 3,303 3,245 58 3,303
Florida – – – 20,604 507 21,111 20,604 507 21,111
Georgia – – – 5,985 79 6,064 5,985 79 6,064
Hawaii – – – 615 4 619 615 4 619
Idaho (June 1986) 172 1 173 127 – 127 299 1 300
Illinois – – – 5,907 95 6,002 5,907 95 6,002
Indiana (July 1988) 2,573 20 2,593 1,533 15 1,548 4,106 35 4,141
Iowa – – – 375 4 379 375 4 379
Kansas – – – 590 4 594 590 4 594
Kentucky – – – 635 7 642 635 7 642
Louisiana (Feb. 1993) 3,910 52 3,962 3,015 50 3,065 6,925 102 7,027
Maine – – – 356 5 361 356 5 361
Maryland – – – 5,377 136 5,513 5,377 136 5,513
Massachussets – – – 3,595 68 3,663 3,595 68 3,663
Michigan (April 1992) 2,672 70 2,742 2,885 28 2,913 5,557 98 5,655
Minnesota (Oct. 1985) 1,949 21 1,970 1,057 11 1,068 3,006 32 3,038
Mississippi (Aug. 1988) 2,978 37 3,015 956 17 973 3,934 54 3,988
Missouri (Oct. 1987) 3,300 38 3,338 2,715 15 2,730 6,015 53 6,068
Montana – – – 68 – 68 68 – 68
Nebraska (Sept. 1995) 123 2 125 266 3 269 389 5 394
Nevada (Feb. 1992) 1,875 18 1,893 1,117 11 1,128 2,992 29 3,021
New Hampshire – – – 305 3 308 305 3 308
New Jersey (Jan. 1992) 9,558 293 9,851 9,854 250 10,104 19,412 543 19,955
New Mexico – – – 459 2 461 459 2 461
New York – – – 28,702 690 29,392 28,702 690 29,392
North Carolina (Feb. 1990) 5,861 68 5,929 2,579 49 2,628 8,440 117 8,557
North Dakota (Jan. 1988) 40 – 40 21 – 21 61 – 61
Ohio (June 1990) 2,184 28 2,212 2,640 34 2,674 4,824 62 4,886
Oklahoma (June 1988) 1,528 11 1,539 983 4 987 2,511 15 2,526
Oregon – – – 1,347 5 1,352 1,347 5 1,352
Pennsylvania – – – 5,841 89 5,930 5,841 89 5,930
Rhode Island – – – 571 5 576 571 5 576
South Carolina (Feb. 1986) 5,292 87 5,379 2,476 25 2,501 7,768 112 7,880
South Dakota (Jan. 1988) 135 5 140 36 2 38 171 7 178
Tennessee (Jan. 1992) 3,311 41 3,352 2,129 18 2,147 5,440 59 5,499
Texas (Feb. 1994)4 – 203 203 14,064 133 14,197 14,064 336 14,400
Utah (April 1989) 767 5 772 464 6 470 1,231 11 1,242
Vermont – – – 118 1 119 118 1 119
Virginia (July 1989) 5,739 54 5,793 3,090 75 3,165 8,829 129 8,958
Washington – – – 2,727 11 2,738 2,727 11 2,738
West Virginia (Jan. 1989) 347 1 348 234 3 237 581 4 585
Wisconsin (Nov. 1985) 1,816 26 1,842 1,068 9 1,077 2,884 35 2,919
Wyoming (June 1989) 54 – 54 53 – 53 107 – 107
Subtotal 69,159 1,254 70,413 181,610 2,838 184,448 250,769 4,092 254,861
Guam – – – 4 – 4 4 – 4
Pacific Islands, U.S. – – – – – – – – –
Puerto Rico – – – 6,008 160 6,168 6,008 160 6,168
Virgin Islands, U.S. – – – 145 10 155 145 10 155
Total 69,159 1,254 70,413 187,767 3,008 190,775 256,926 4,262 261,188
1Persons reported with vital status “alive” as of the last update.
2Includes only persons reported from states with confidential HIV reporting. Excludes 1,601 adults/adolescents and 26 children reported from states with
confidential HIV infection reporting whose state of residence is unknown or are residents of other states.
3Includes 262 adults/adolescents and 2 children whose state of residence is unknown.
4Connecticut and Texas have confidential HIV infection reporting for pediatric cases only.
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Surveillance of AIDS
All 50 states, the District of Columbia, U.S. dependencies
and possessions, and independent nations in free
association with the United States1 report AIDS cases to
CDC using a uniform surveillance case definition and case
report form. The original definition was modified in 1985
(MMWR 1985;34:373-75) and 1987 (MMWR 1987;36[suppl
no. 1S]:1S-15S). The case definition for adults and adoles-
cents was modified again in 1993 (MMWR 1992;41[no.
RR-17]:1-19; see also MMWR 1995; 44:160-61, 64-67).
The revisions incorporated a broader range of AIDS-
indicator diseases and conditions and used HIV diagnostic
tests to improve the sensitivity and specificity of the
definition. The laboratory and diagnostic criteria for the
1987 pediatric case definition (MMWR 1987;36:225-30,
235) were updated in 1994 (MMWR  1994;43[no. RR-12]:
1-19).
For persons with laboratory-confirmed HIV infection, the
1987 revision incorporated HIV encephalopathy, wasting
syndrome, and other indicator diseases that are diagnosed
presumptively (i.e., without confirmatory laboratory
evidence of the opportunistic disease). In addition to the 23
clinical conditions in the 1987 definition, the 1993 case
definition for adults and adolescents includes HIV-infected
persons with CD4+ T-lymphocyte counts of less than 200
cells/µL or a CD4+ percentage of less than 14, and persons
diagnosed with pulmonary tuberculosis, recurrent pneu-
monia, and invasive cervical cancer. All conditions added
to the 1993 definition require laboratory confirmation of HIV
infection. Persons who meet the criteria for more than one
definition category are classified hierarchically in the
following order: pre-1987, 1987, and 1993. Persons in the
1993 definition category meet only the 1993 definition.
The pediatric case definition incorporates the revised
1994 pediatric classification system for evidence of HIV
infection. Children with their first positive results on
Western blot or HIV detection tests before October 1994
were categorized based on the 1987 classification system.
Those tested during or after October 1994 are categorized
under the revised 1994 pediatric classification system. For
children of any age with an AIDS-defining condition that
requires evidence of HIV infection, a single positive HIV-
detection test (i.e., HIV culture, HIV PCR, or HIV antigen
[p24]) is sufficient for a reportable AIDS diagnosis if the
diagnosis is confirmed by a physician. The 1994 pediatric
definitions for HIV encephalopathy and HIV wasting
syndrome reflect increased knowledge of these conditions
in children, and replace the 1987 definitions.
Although completeness of reporting of diagnosed AIDS
cases to state and local health departments varies by
geographic region and patient population, studies
conducted by state and local health departments indicate
that reporting of AIDS cases in most areas of the United
States is more than 85 percent complete (J Acquir Immune
Def Syndr, 1992;5:257-64 and Am J Public Health
1992;82:1495-99). In addition, multiple routes of exposure,
opportunistic diseases diagnosed after the initial AIDS
case report was submitted to CDC, and vital status may not
be determined or reported for all cases.
Included in this report are persons known to be infected
with human immunodeficiency virus type 2 (HIV-2). See
MMWR 1995;44:603-06.
Surveillance of HIV infection (not AIDS)
Through December 31, 1995, 26 states had laws or
regulations requiring confidential reporting by name of all
persons with confirmed HIV infection, in addition to
reporting of persons with AIDS. Two other states,
Connecticut and Texas, required reporting by name of HIV
infection only for children less than 13 years of age. These
states initiated reporting at various times after the
development of serum HIV-antibody tests in 1985. Before
1991, surveillance of HIV infection was not standardized
and reporting of HIV infections was based primarily on
passive surveillance. Consequently, many cases reported
before 1991 do not have complete information. Since then,
CDC has assisted states in conducting active surveillance
of HIV infection using standardized report forms and
software. However, collection of demographic and risk
information still varies greatly among states.
HIV infection data should be interpreted with caution.
HIV surveillance reports are not representative of all
persons with HIV infection. Because many HIV-reporting
states also offer anonymous HIV testing, confidential HIV
infection reports are not representative of all persons being
tested in these areas. Furthermore, many factors may
influence testing patterns, including the extent that testing
is targeted or routinely offered to specific groups and the
availability and access to medical care and testing
services. These data provide a minimum estimate of the
number of persons known to be HIV infected in states with
confidential HIV infection reporting.
For this report, persons greater than 18 months of age
were considered HIV infected if they had at least one
Technical Notes
1Included among the dependencies, possessions, and independent na-
tions are Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa,
the Republic of Palau, the Republic of the Marshall Islands, the Com-
monwealth of the Northern Mariana Islands, and the Federated States of
Micronesia. The latter 5 comprise the category “Pacific Islands, U.S.”
listed in Tables 1 and 27.
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positive Western blot or positive detection test (culture,
antigen, or other detection test) or had a diagnosis of HIV
infection documented by a physician. Before October
1994, children less than 15 months of age were considered
HIV infected if they met the definition stated in the 1987
pediatric classification system for HIV infection (MMWR
1987;36:225-30, 235). Beginning October 1994, children
less than 18 months of age are considered HIV infected if
they meet the definition stated in the 1994 pediatric
classification system for HIV infection (MMWR 1994;43[no.
RR-12]:1-10). This report also includes children who were
diagnosed as HIV infected by a physician. Although many
states monitor reports of children born to infected mothers,
only those with documented diagnosis of HIV infection are
included in this report.
Because states initiated reporting on different dates, the
length of time reporting has been in place will influence the
number of HIV infection cases reported. For example, data
presented for a given annual period may include cases
reported during only a portion of the year. Prior to statewide
HIV reporting, some states collected reports of HIV
infection in selected populations. Therefore, these states
have reports prior to initiation of statewide confidential
reporting.
Over time, persons with HIV infection will be diagnosed
and reported with AIDS. HIV infection cases later reported
with AIDS are deleted from the HIV infection tables and
added to the AIDS tables. Persons with HIV infection may
be tested at any point in the clinical spectrum of disease,
therefore the time between diagnosis of HIV infection and
AIDS will vary. In addition, because surveillance practices
differ, reporting and updating of clinical and vital status of
cases vary among states.
Included in this report are persons known to be infected
with human immunodeficiency virus type 2 (HIV-2). See
MMWR 1995;44:603-06.
Tabulation and presentation of HIV infection
and AIDS data
Data in this report are provisional. Each issue of this
report includes information received by CDC through the
last day of the reporting period. AIDS data are tabulated by
date of report to CDC unless otherwise noted. Data for U.S.
dependencies and possessions and for associated
independent nations are included in the totals.
Age group tabulations are based on the person’s age at
first documented positive HIV-antibody test result for HIV
infection cases, and age at diagnosis of AIDS for AIDS
cases. Adult/adolescent cases include persons 13 years of
age and older; pediatric cases include children under 13
years of age. Age group tabulations for AIDS cases in
Table 14 (year-end edition only) are based on age at death.
Tabulations of persons living with HIV and AIDS (Table 27),
include persons whose vital status was “alive” as of the last
update; persons whose vital status is missing or unknown
are not included. Caution should be used in interpreting
these data because states vary in the frequency with which
they review the vital status of persons reported with HIV
infection and AIDS. In addition, some cases may be lost to
follow-up.
Table 12 (year-end edition only) tabulates AIDS-
indicator conditions reported during the last year. These
data are known to underreport AIDS-indicator conditions
and should be interpreted with caution. Reported
conditions overrepresent initial AIDS-indicator illness
because follow-up for subsequent indicator diseases is
resource intensive and has not been systematic or
standardized in most health departments. The 1993 AIDS
surveillance case definition for adults and adolescents
added reporting of HIV-infected persons with severe HIV-
related immunosuppression (CD+ T-lymphocyte count of
less than 200/µL or less than 14 percent). Since
implementation of the 1993 definition, approximately half of
all cases were reported based only on immunologic criteria;
consequently, reporting of AIDS cases based on AIDS-
defining opportunistic infections has decreased (see AIDS
1994;8:1489-93).
Table 2 lists AIDS case counts for each metropolitan
area with 500,000 or more population. AIDS case counts
for metropolitan areas with 50,000 to 500,000 population
are reported as a combined subtotal. On December 31,
1992, the Office of Management and Budget announced
new Metropolitan Statistical Area (MSA) definitions, which
reflect changes in the U.S. population as determined by the
1990 census. These definitions were updated most
recently on July 1, 1994. The cities and counties which
compose each metropolitan area listed in Table 2 are
provided in the publication “Metropolitan Areas as of
June 30, 1995” (available by calling the National Technical
Information Service, 1–703–487–4650, and ordering
accession no. PB95-208880). Standards for defining
central and outlying counties of metropolitan areas were
published in the Federal Register (see FR 1990;55:
12154-60).
The metropolitan areas definitions are the MSAs for all
areas except the 6 New England states. For these states,
the New England County Metropolitan Areas (NECMA) are
used. Metropolitan areas are named for a central city in the
MSA or NECMA, may include several cities and counties,
and may cross state boundaries. For example, AIDS cases
and annual rates presented for the District of Columbia in
Table 1 include only persons residing within the geographic
boundaries of the District. AIDS cases and annual rates for
Washington, D.C., in Table 2 include persons residing
within the several counties in the metropolitan area,
including counties in Maryland, Virginia, and West Virginia.
State or metropolitan area data tabulations are based on
the person’s residence at first positive HIV-antibody test
result for HIV infection cases and residence at diagnosis of
the first AIDS-indicator condition(s) for AIDS cases.
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Estimated AIDS-opportunistic illness
In 1993, the AIDS surveillance case definition was
expanded to include a laboratory measure of severe
immunosuppression (CD4+ T-lymphocyte count of less
than 200 cells/µL or a percent of total lymphocytes less than
14) and three additional clinical conditions (pulmonary
tuberculosis, recurrent pneumonia, and invasive cervical
cancer). Before 1993, the surveillance definition included
only opportunistic illnesses, and trends in the incidence of
AIDS were evaluated by examining the number of AIDS
opportunistic illnesses (AIDS-OIs) diagnosed per year or
quarter (adjusted for reporting delays). Because most HIV-
infected persons become severely immunosuppressed
before the onset of AIDS-OIs, the addition of the CD4+
criteria has temporarily distorted observed trends in AIDS
incidence. To examine trends over time, an additional
adjustment is required to estimate when an AIDS-OI will
develop in persons who were reported based on the CD4+
criteria. CDC has developed a procedure to estimate the
incidence of AIDS-OIs among persons reported with AIDS
based on the CD4+ criteria. Estimates of trends in AIDS-OIs
are displayed in Tables 18, 19, and 20.
The estimated AIDS-OI incidence is the sum of incidence
in two groups. The first group is persons reported to AIDS
surveillance with AIDS-OIs. Incidence in this group is
estimated by adjusting reported cases for delays in case
reporting.
The second group is persons reported with AIDS based
on a CD4+ count or percent. Most of these persons will
eventually have an AIDS-OI diagnosed. CDC has
estimated the number of persons who had or will have an
AIDS-OI diagnosed after the date of the reported CD4+
count or percent, by month of AIDS-OI diagnosis. To do
this, CDC used data from the Adult Spectrum of Disease
Project (see JAMA 1992;267:1798-1805) to estimate the
probability distribution of the time interval between a CD4+
count in a particular range (e.g., 0 to 29 cells/µL, 30 to 59
cells/µL, etc.) and the diagnosis of an AIDS-OI. This
probability distribution is the proportion of persons with a
CD4+ count in a given range who will have an AIDS-OI
diagnosed 1 month, 2 months, etc., after the reported CD4+
count. The expected number of persons with an AIDS-OI
diagnosed in each later month among persons whose CD4+
count was in a particular range during a given month is the
product of the number of these persons and the proportion
expected to have an AIDS-OI diagnosed in this later month.
The estimate of the number of AIDS-OI diagnoses in a
particular month among persons reported with AIDS based
on the CD4+ criteria is the sum, over all combinations of
CD4+ ranges and previous months, of the number of
persons expected to be diagnosed with an AIDS-OI in the
month for which the estimate is made.
There is uncertainty in these estimates of AIDS-OI
incidence. Some uncertainty is the result of the need to
adjust for delays in reporting of AIDS cases. There is
additional uncertainty because some persons reported
with AIDS based on the CD4+ criteria die before an AIDS-
OI is diagnosed and hence should not contribute to the
AIDS-OI incidence estimate. Other persons reported with
AIDS based on the CD4+ criteria have an unreported AIDS-
OI diagnosis by the date of the CD4+ determination; the
estimation procedure counts their contribution to AIDS-OI
incidence later than it should. However, preliminary
analyses show that these two sources of bias change
estimated AIDS-OI incidence by only a few percentage
points.
Reporting delays were estimated by a maximum
likelihood statistical procedure, taking into account
possible differences in reporting delays among exposure,
geographic, racial/ethnic, age, and sex categories, but
assuming that reporting delays within these groups have
not changed over time (see Lecture Notes in Biomathe-
matics 1989;83:58-88).
The regions of residence included in Table 18 are
defined as follows. Northeast: Connecticut, Maine,
Massachusetts, New Hampshire, New Jersey, New York,
Pennsylvania, Rhode Island, and Vermont; Midwest:
Indiana, Illinois, Iowa, Kansas, Michigan, Minnesota,
Missouri, Nebraska, North Dakota, Ohio, South Dakota,
and Wisconsin; South: Alabama, Arkansas, Delaware,
District of Columbia, Florida, Georgia, Kentucky,
Louisiana, Maryland, Mississippi, North Carolina, Okla-
homa, South Carolina, Tennessee, Texas, Virginia, and
West Virginia; West: Alaska, Arizona, California, Colorado,
Idaho, Hawaii, Montana, Nevada, New Mexico, Oregon,
Utah, Washington, and Wyoming; Territories: Guam,
Puerto Rico, the U.S. Virgin Islands, and the U.S. Pacific
Islands listed on page 36.
Exposure categories
For surveillance purposes, HIV infection cases and
AIDS cases are counted only once in a hierarchy of
exposure categories. Persons with more than one reported
mode of exposure to HIV are classified in the exposure
category listed first in the hierarchy, except for men with
both a history of sexual contact with other men and
injecting drug use. They make up a separate exposure
category.
“Men who have sex with men” cases include men who
report sexual contact with other men (i.e., homosexual
contact) and men who report sexual contact with both men
and women (i.e., bisexual contact). “Heterosexual contact”
cases are in persons who report specific heterosexual
contact with a person with, or at increased risk for, HIV
infection (e.g., an injecting drug user).
Adults/adolescents born, or who had sex with someone
born, in a country where heterosexual transmission was
believed to be the predominant mode of HIV transmission
(formerly classified as Pattern-II countries by the World
HIV/AIDS Surveillance Report 38 Vol. 7, No. 2
Health Organization) are no longer classified as having
heterosexually acquired AIDS. Similar to case reports for
other persons who are reported without behavioral or
transfusion risks for HIV, these reports are now classified
(in the absence of other risk information which would
classify them into another exposure category) as “no risk
reported or identified” (see MMWR 1994;43:155-60).
Children whose mother was born, or whose mother had sex
with someone born, in a Pattern-II country are now
classified (in the absence of other risk information which
would classify them into another exposure category) as
“Mother with/at risk for HIV infection: has HIV infection, risk
not specified.”
“No risk reported or identified” cases are in persons with
no reported history of exposure to HIV through any of the
routes listed in the hierarchy of exposure categories. Risk
not identified cases include persons who are currently
under investigation by local health department officials;
persons whose exposure history is incomplete because
they died, declined to be interviewed, or were lost to follow-
up; and persons who were interviewed or for whom other
follow-up information was available and no exposure mode
was identified. Persons who have an exposure mode
identified at the time of follow-up are reclassified into the
appropriate exposure category. In general, investigations
and follow up for modes of exposure by state health
departments are conducted routinely for persons reported
with AIDS and as resources allow for those reported with
HIV infection. Therefore, the percentage of HIV infected
persons with risk not reported or identified is substantially
higher than for those reported with AIDS. As HIV infected
persons with risk not reported or identified are diagnosed
and reported with AIDS, they are assigned higher priority
for follow-up to determine the mode(s) of exposure.
Rates
Rates are calculated on a 12-month basis per 100,000
population for AIDS cases only. Rates are not calculated
for HIV infection reports because case counts for HIV
infection are believed to be less complete than AIDS case
counts. Population denominators for computing AIDS rates
for the 50 states and the District of Columbia are based on
official postcensus estimates from the U.S. Bureau of
Census. Denominators for U.S. dependencies and
possessions are linear extrapolations of official 1980 and
1990 census counts. Each 12-month rate is the number of
cases reported during the 12-month period, divided by the
1994 or 1995 population, multiplied by 100,000. The
denominators for computing race-specific rates (Table 10,
year-end edition only) are based on 1990 census
projections published in U.S. Bureau of Census publication
P25-1104, “Population Projections of the United States, by
Age, Sex, Race, and Hispanic Origin: 1993 to 2050.” Race-
specific rates are the number of cases reported for a
particular racial/ethnic group during the preceding 12-
month period divided by the projected population for that
race/ethnicity, multiplied by 100,000.
Case-fatality rates are calculated for each half-year by
date of diagnosis of AIDS. Each 6-month case-fatality rate
is the number of deaths ever reported among cases
diagnosed in that period (regardless of the year of death),
divided by the number of total cases diagnosed in that
period, multiplied by 100. Reported deaths are not
necessarily caused by HIV-related disease. Caution
should be used in interpreting case-fatality rates because
reporting of deaths is incomplete (see Am J Public Health
1992;82:1500-05 and Am J Public Health 1990;80:1080-86).
Reporting delays
Reporting delays (time between diagnosis of HIV
infection or AIDS and report to CDC) vary widely among
exposure, geographic, racial/ethnic, age and sex
categories, and have been as long as several years for
some AIDS cases. About 50 percent of all AIDS cases were
reported to CDC within 3 months of diagnosis, with about
20 percent being reported more than one year after
diagnosis. Reporting delay for HIV infection cases is being
evaluated.
